Shibayama Hirohiko 柴山浩彦

… Alternative Names

SHIBAYAMA Hirohiko 柴山浩彦

Less

Researcher Number	60346202
Other IDs
Affiliation (Current)	2025: 独立行政法人国立病院機構大阪医療センター(臨床研究センター), その他部局等, 科長・グループリーダークラス
Affiliation (based on the past Project Information) *help	2021: 大阪大学, 医学系研究科, 招へい教授 2020: 大阪大学, 医学系研究科, 招聘教授 2017 – 2020: 大阪大学, 医学系研究科, 准教授 2015 – 2016: 大阪大学, 医学系研究科, 講師 2015: 大阪大学, 大学院医学系研究科, 講師 … More 2011 – 2015: 大阪大学, 医学(系)研究科(研究院), 講師 2013: 大阪大学, 大学院医学系研究科, 講師 2010 – 2012: 大阪大学, 医学系研究科, 講師 2010 – 2011: 大阪大学, 大学院・医学系研究科, 講師 2007 – 2009: Osaka University, Graduate School of Medicine, Assistant Professor 2007: 大阪大学, 医学系・研究科, 助教 2002 – 2006: Osaka University, Graduate School Of Medicine, Assistant Professor, 医学系研究科, 助手 2001: Osaka University Hospital, Medical Staff, 医学部附属病院, 医員(臨床研究) Less
Review Section/Research Field	Principal Investigator Hematology / Basic Section 54010:Hematology and medical oncology-related Except Principal Investigator Hematology / Hematology / Biological Sciences / Basic Section 54010:Hematology and medical oncology-related
Keywords	Principal Investigator アナモルシン / Bリンパ球 / 遺伝子改変マウス / 鉄・硫黄クラスター / アポトーシス / PICOT / PKCθ / Yeast-two-hybrid / Anamorsin / Bcl-xL … More / Jak2 / 抗アポトーシス / P38MAPK / p38MAPK / B リンパ球 / Picot / 骨髄異形成症候群 / 鉄過剰 / RNA-Seq / 造血幹細胞 / 条件付き遺伝子欠損マウス / 遺伝子欠損マウス / 鉄硫黄クラスター蛋白 / リンパ球 / 免疫学 / T リンパ球 / Tリンパ球 / コンディショナルノックアウトマウス / apoptosis / Yeast-two-hybrid法 / DNA microarray / knock-out mouse / definitive hematopoiesis / anti-apoptosis / Bcl-2 / Bcl-xL Jak2 / DNAマイクロアレイ / ノックアウトマウス / 二次造血 / RAS / 炎症 / BCRシグナル / 鉄代謝 / PKC / IkB / ERK1/2 / LPS / 生物学的予後指標 / トランスジェニックマウス / 悪性リンパ腫 … More Except Principal Investigator 造血幹細胞 / アポトーシス / FLT3 / 白血病 / 分化 / アナモルシン / Anamorsin / c-myc / ROS / Notch / c-Kit / AML / STAT3 / STAT / 鉄・硫黄クラスター / 増殖 / Ras / チロシンキナーゼ / NF-κB / HOXB4 / 細胞周期 / apoptosis / シグナル伝達 / KIT / mutation / コンディショナルノックアウトマウス / 活性化変異 / 骨髄微小環境 / SIRT1 / activation loop / E2F1 / 自己複製 / signal transduction / chaperone / leukemia / tyrosine kinase / 急性骨髄性白血病 / p27Kip1 / p21WAF1 / GATA-2 / GATA-1 / Bcl-XL / NF-kB / 活性酸素種 / inhibitor / Targeting therapy / Receptor tyrosine kinase / CD59 / PIG-A / PNH / 間葉系幹細胞 / 骨髄異形成症候群 / 鉄代謝 / 樹状細胞 / 鉄硫黄クラスター / Picot / 遺伝子改変マウス / 未分化性 / Sirt1 / エネルギー代謝 / PML / Gene-Trap法 / 造血器腫瘍 / トランスジェニックマウス / 分子標的療法 / サイトカイン / c-Myc / 赤血球造血 / 胎仔肝 / 造血発生 / ESAM / 血管内皮細胞 / 免疫再構築 / 胸腺再生 / STAP蛋白 / STAP / リンパ球 / 同種移植 / GVHD / 同種造血幹細胞移植 / 微小環境 / 造血微小環境 / 多発性骨髄腫 / 血液内科学 / 内科 / 赤血球分化 / 貧血 / prolifferation / differentiation / Hematopoietic stem cell / p19Af / PI3K / 活性酸素 / MAPK / p53 / p16INK4a / レセプター / hematopoietic stem cell / apootosis / oncogenesis / oncogene / シャペロン蛋白 / 腫瘍化 / 急性白血病 / c-kit / mitochondrial membrane potential / cytokine / reactive oxygen species / OP9システム / H2O2 / ミトコンドリア膜電位 / hematopoietic Stem Cell / 細胞増殖 / RARα / 転写因子 / chemotaixs / Acute myeloid leukemia / AG1296 / STI571 / PI3-K / targeting therapy / acute myeloid leukemia / receptor tyrosine kinase / chemotaxis / Acute myeloid Ieukemia / missense mutation / clonal expansion / Aplastic anemia / bone marorow failure / GPI-anchor / レトロウイルスベクター / PIG-A遺伝子 / HMGA2 / ミスセンス変異 / クローン拡大 / 再生不良性貧血 / 造血不全 / GPIアンカー / 遺伝子多型 / 補体 / エクリズマブ / 溶血 / 発作性夜間ヘモグロビン尿症 / ヘプシジン / アルブミンCreトランスジェニックマウス / アナモルシン　コンディショナルノックアウトマウス / ｐDC / ｃDC / DC / 白血病関連遺伝子変異 / 組織球系腫瘍 / pDC / cDC / 白血病関連遺伝子 / 疾患特異的 / iPS細胞 / 細胞内鉄代謝 / 鉄硫黄クラスター蛋白 / P38MAPK / PKC / P53 / IkB / ERK1/2 / トランスジェニック / PICOT / B細胞性リンパ腫 / LPS / Bリンパ球 / 細胞内シグナル伝達 / Tet-offシステム / 白血病原因遺伝子 / ES細胞 / 白血病幹細胞 / 4倍体胚補完法 / multiple myeloma / FGFR3 / class II mutation / class I mutation / plasmacytoid DC / ER stress / プロテアゾーム阻害剤 / レセプター型チロシンキナーゼ / 血液腫瘍学 / 造血支持細胞 / 造血 / Niche / グルコース濃度 / 増殖シグナル / 活性型チロシンキナーゼ / 慢性骨髄性白血病 / 遺伝子変異 / 細胞老化 / 悪性リンパ腫 / チロシンキナーゼ阻害剤 / キナーゼ領域変異 / レセプターチロシンキナーゼ / TERT / 細胞接着 / 不死化 / テロメラーゼ / E2F-1 / 癌抑制遺伝子 Less

Role of mesenchymal stromal cells in multiple myeloma
- Principal Investigator
  
  Ichii Michiko
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Osaka University
Role of STAP proteins in allogeneic hematopoietic stem cell transplantation
- Principal Investigator
  
  Saitoh Hideaki
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Osaka University
Evaluation of iron-sulfur proteins in hematopoietic cells through anamorsinPrincipal Investigator
- Principal Investigator
  
  Shibayama Hirohiko
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Osaka University
Mechanism by which deficiency of hematopoietic stem cell antigen ESAM leads to lethal erythropoietic failure during fetal life
- Principal Investigator
  
  Ueda Tomoaki
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Osaka University
Analysis of the role of Anamorsin in erythrocyte differentiation using conditional knockout mice.
- Principal Investigator
  
  Kurashige Ryumei
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Clarification of the roles of anamorsin in the lymphocytes differentiation and proliferationPrincipal Investigator
- Principal Investigator
  
  SHIBAYAMA HIROHIKO
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Functional analysis of Anamorsin in iron metabolism in vivo
- Principal Investigator
  
  HAMANAKA Yuri
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Investigation of eculizumab therapeutic response to patients with PNH
- Principal Investigator
  
  NISHIMURA Jun-ichi
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Analysis of the functions of anti-apoptotic molecule, Anamorsin -the roles in hematopoiesis and cellular iron metabolism-
- Principal Investigator
  
  KANAKURA Yuzuru
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
The analysis of bone marrow microenvironment in myelodysplastic syndrome using patient-derived iPS cells
- Principal Investigator
  
  EZOE Sachiko
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Dendritic cell differentiation from myeloid neoplasm
- Principal Investigator
  
  Mizuki Masao
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Analysis of the roles of anti-apoptotic molecule, Anamorsin in immune cellsPrincipal Investigator
- Principal Investigator
  
  SHIBAYAMA Hirohiko
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Development of novel anti-tumor drugs inhibiting Anamorsin and Picot binding
- Principal Investigator
  
  SAITOH Norimitsu
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Analysis of functions of anamorsin, an anti-apoptotic molecule, in hematopoiesis
- Principal Investigator
  
  KANAKURA Yuzuru
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Analysis of the roles of anamorsin, anti-apoptotic molecule, onsurvival and proliferation of B lymphocytesPrincipal Investigator
- Principal Investigator
  
  SHIBAYAMA Hirohiko
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Analysis of weak points in oncogenic tyrosine kinase-dependent growth
- Principal Investigator
  
  MIZUKI Masao
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Analysis of leukemogenic transgenic mice generated by tetraploid embryonic complementation method using Tet-off system.
- Principal Investigator
  
  MATSUMURA Itaru
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Hematology
- Research Institution
  Kinki University
Energy metabolism in the growth and differentiation of hematopoietic stem/ progentor cells
- Principal Investigator
  
  EZOE Sachiko
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Roles of leukemogenic oncogenes in the regulation of metabolism, growth, and differentiation of hematopoietic stem cells
- Principal Investigator
  
  MATSUMURA Itaru
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Clarification of functions of Anamorsin, anti-apoptotic molecule, and its roles in malignant lymphomasPrincipal Investigator
- Principal Investigator
  
  SHIBAYAMA Hirohiko
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
新規Gene-Trap法による多段階の白血病発症に関わる遺伝子単離の試み
- Principal Investigator
  
  松村到
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Osaka University
造血細胞における細胞老化克服遺伝子の単離と機能解析
- Principal Investigator
  
  松村到
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Exploratory Research
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Synthetic Analysis on the mechanisms of survival and differentiation of hematopoietic cells
- Principal Investigator
  
  KANAKURA Yuzuru
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Novel signal transduction pathways in constitutive active mutants of receptor tyrosine kianses
- Principal Investigator
  
  MIZUKI Masao
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
The function of Sir2 in proliferation and aging of hematopoietic cells
- Principal Investigator
  
  EZOE Sachiko
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Notchの活性化変異による白血病発症機構の解析
- Principal Investigator
  
  松村到
- Project Period (FY)
  2005
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Osaka University
Clarification of mechanism of anamorsin, anti-apoptotic moleculePrincipal Investigator
- Principal Investigator
  
  SHIBAYAMA Hirohiko
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
細胞周期制御分子による造血幹細胞の未分化能の維持及び増幅の試み
- Principal Investigator
  
  SUGAHARA Hiroyuki
- Project Period (FY)
  2004
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
造毛器腫瘍における抗アポトーシス分子アナモルシンの役割
- Principal Investigator
  
  松村到
- Project Period (FY)
  2004 – 2005
- Research Category
  
  Grant-in-Aid for Exploratory Research
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Analysis on the mechanisms of growth, differentiation, and survival of megakaryocytic cells
- Principal Investigator
  
  KANAKURA Yuzuru
- Project Period (FY)
  2004 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Analysis on the mechanisms of NF-κB/Reactive Oxigen Species-mediated survival of hematopoietic cells and its clinical application
- Principal Investigator
  
  MATSUMURA Itaru
- Project Period (FY)
  2004 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Mechanism of leukemogenesis by constitutive active receptor tyrosine kinase
- Principal Investigator
  
  MIZUKI Masao
- Project Period (FY)
  2004 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
E2F1による細胞内ROSの蓄積及び癌抑制機構の解析
- Principal Investigator
  
  松村到
- Project Period (FY)
  2003
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Osaka University
活性化変異c-Kit,Flt3の異常シグナル伝達を標的とした治療法の開発
- Principal Investigator
  
  水木満佐央
- Project Period (FY)
  2003
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Osaka University
Anamorsin, anti-apoptotic molecule, and hematopoiesisPrincipal Investigator
- Principal Investigator
  
  SHIBAYAMA Hirohiko
- Project Period (FY)
  2003 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
E2F-1のアポトーシス誘導分子、癌抑制遺伝子としての機能の解析
- Principal Investigator
  
  MATSUMURA ITARU
- Project Period (FY)
  2002
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Osaka University
造血幹細胞におけるテロメラーゼ活性の制御機構の解析と制御分子の単離の試み
- Principal Investigator
  
  金倉譲
- Project Period (FY)
  2002 – 2003
- Research Category
  
  Grant-in-Aid for Exploratory Research
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Analysis on the mechanism of survival, growth and differentiation of hematopoietic cells
- Principal Investigator
  
  KANAKURA Yuzuru
- Project Period (FY)
  2002 – 2003
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Analysis on the effects of GATA transcription factors on cell cycle regulatoy molecules in hematopoietic cells
- Principal Investigator
  
  MATSUMURA Itaru
- Project Period (FY)
  2002 – 2003
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Mechanisms of growth, survival and transformation mediated by KIT and FLT3
- Principal Investigator
  
  KURATSUNE Hirohiko
- Project Period (FY)
  2001 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Establishment of a sensitive method for detection of PIG-A mutations, and some applications for molecular studies of paroxysual necturnal hemoglobinuric
- Principal Investigator
  
  MACHII Takashi
- Project Period (FY)
  2000 – 2001
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University

[Book] がんの新しいバイオマーカー/予測因子による個別化医療時代に求められる抗がん剤開発2011
- Author(s)
  柴山浩彦
- Publisher
  技術情報協会
- Data Source
  KAKENHI-PROJECT-22591034
[Book] ステロイドの使い分け2010
- Author(s)
  西村純一, 柴山浩彦, 水木満佐央, 金倉譲, 他
- Publisher
  羊土社
- Data Source
  KAKENHI-PROJECT-22390194
[Book] 薬剤ごとの違いがわかるステロイドの使い分け2010
- Author(s)
  西村純一, 柴山浩彦, 水木満佐央, 金倉譲
- Publisher
  羊土社
- Data Source
  KAKENHI-PROJECT-22591036
[Book] 看護学テキスト疾病と治療II2010
- Author(s)
  柴山浩彦, 金倉譲, 他
- Publisher
  南江堂
- Data Source
  KAKENHI-PROJECT-22390194
[Journal Article] Nivolumab-induced systemic lymphadenopathy occurring during treatment of malignant melanoma: a case report.2022
- Author(s)
  Kubo T, Hino A, Fukushima K, Shimomura Y, Kurashige M, Kusakabe S, Nagate Y, Fujita J, Yokota T, Kato H, Shibayama H, Tanemura A, Hosen N.
- Journal Title
  
  Int J Hematol
  
  Volume: ー Issue: 2 Pages: 302-306
- DOI
  10.1007/s12185-022-03312-0
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-21K08371
[Journal Article] Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow up of the Japanese subgroup of the randomized ENESTnd trial.2022
- Author(s)
  Nakamae H, Yamamoto M, Sakaida E, Kanda Y, Ohmine K, Ono T, Matsumura I, Ishikawa M, Aoki M, Maki A, Shibayama H.
- Journal Title
  
  Int J Hematol
  
  Volume: 115 Issue: 1 Pages: 33-42
- DOI
  10.1007/s12185-021-03216-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Two-year outcomes of tirabrutinib monotherapy in Waldenstoom's macroglobulinemia.2022
- Author(s)
  Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Iguchi D, Izutsu K.
- Journal Title
  
  Cancer Sci
  
  Volume: ー Issue: 6 Pages: 2085-2096
- DOI
  10.1111/cas.15344
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Impaired B cell terminal differentiation in B cell-specific knockout mice of cell death-defying factor anamorsin.2022
- Author(s)
  Hamanaka Y, Tanimura A, Yokota T, Ezoe S, Ichii M, Nagate Y, Oritani K, Kanakura Y, Hosen N, Shibayama H.
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 603 Pages: 1-6
- DOI
  10.1016/j.bbrc.2022.03.018
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-21K08415
[Journal Article] Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.2022
- Author(s)
  Edahiro Y, Ohishi K, Gotoh A, Takenaka K, Shibayama H, Shimizu T, Usuki K, Shimoda K, Ito M, VanWart SA, Zagrijtschuk O, Qin A, Kawase H, Miyachi N, Sato T, Komatsu N, Kirito K.
- Journal Title
  
  Int J Hematol
  
  Volume: ー Issue: 2 Pages: 215-227
- DOI
  10.1007/s12185-022-03341-9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-20H03713, KAKENHI-PROJECT-21H02949
[Journal Article] Identification of CXCL12-abundant reticular cells in human adult bone marrow2021
- Author(s)
  Aoki K, Kurashige M, Ichii M, Higaki K, Sugiyama T, Kaito T, Ando W, Sugano N, Sakai T, Shibayama H; HANDAI Clinical Blood Club, Takaori-Kondo A, Morii E, Kanakura Y, Nagasawa T.
- Journal Title
  
  Br J Haematol .
  
  Volume: x Issue: 3 Pages: 659-668
- DOI
  10.1111/bjh.17396
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08814, KAKENHI-PROJECT-18H03998, KAKENHI-PROJECT-19K08837, KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-19K16585
[Journal Article] Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma2021
- Author(s)
  Takakuwa Teruhito、Ohta Kensuke、Nakatani Eiji、Ito Tomoki、Kaneko Hitomi、Fuchida Shin‐Ichi、Shimura Yuji、Yagi Hideo、Shibayama Hirohiko、Kanda Junya、Uchiyama Hitoji、Kosugi Satoru、Tanaka Hirokazu、Kawata Eri、Uoshima Nobuhiko、Ishikawa Jun、Shibano Masaru、Karasuno Takahiro、Shindo Maki、Shimizu Yoshifumi、等
- Journal Title
  
  Hematological Oncology
  
  Volume: 未定 Issue: 3 Pages: 349-357
- DOI
  10.1002/hon.2863
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K18445, KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-20K08743
[Journal Article] Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial2021
- Author(s)
  Murai K, Ureshino H, Kumagai T, Tanaka H, Nishiwaki K, Wakita S, Inokuchi K, Fukushima T, Yoshida C, Uoshima N, Kiguchi T, Mita M, Aoki J, Kimura S, Karimata K, Usuki K, Shimono J, Chinen Y, Kuroda J, Matsuda Y, Nakao K, Ono T, Fujimaki K, Shibayama H, Sakamoto J, Kimura S.
- Journal Title
  
  Lancet Haematol
  
  Volume: 8 Issue: 12 Pages: e902-e911
- DOI
  10.1016/s2352-3026(21)00333-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-20K07150, KAKENHI-PROJECT-20K08756, KAKENHI-PROJECT-21K16245
[Journal Article] Pretreatment levels of serum soluble interleukin-2 receptor are useful in selecting the treatment regimen for newly diagnosed advanced-stage follicular lymphoma with low tumor burden.2021
- Author(s)
  Nozaki K, Sugahara H, Ueda S, Ishikawa J, Karasuno T, Iida M, Kamae T, Moriyama Y, Kawakami M, Kosugi S, Nakagawa M, Azenishi Y, Sakaniwa R, Kitamura T, Shibayama H.
- Journal Title
  
  Int J Hematol
  
  Volume: 114 Issue: 2 Pages: 217-221
- DOI
  10.1007/s12185-021-03151-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma Forum.2021
- Author(s)
  Nakaya A, Shibayama H, Nakatani E, Shimura Y, Kosugi S, Tanaka H, Fuchida S, Kanda J, Uoshima N, Kaneko H, Imada K, Ohta K, Ito T, Yagi H, Yoshihara S, Hino M, Shimazaki C, Takaori-Kondo A, Kuroda J, Matsumura I, Kanakura Y, Nomura S.
- Journal Title
  
  eJHaem
  
  Volume: 2 Pages: 765-773
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Flow cytometry analysis of peripheral Tregs in patients with multiple myeloma under lenalidomide maintenance.2021
- Author(s)
  Nozaki K, Fujioka Y, Sugiyama D, Ishikawa J, Iida M, Shibata M, Kosugi S, Nishikawa H, Shibayama H.
- Journal Title
  
  Int J Hematol
  
  Volume: 113 Issue: 5 Pages: 772-774
- DOI
  10.1007/s12185-021-03093-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-17H06162
[Journal Article] Subcutaneous delivery of daratumumab in Japanese patients with relapsed/refractory multiple myeloma.2021
- Author(s)
  Shibayama H, Matsumoto M, Kosugi H, Shibayama K, Yamazaki H, Iida S.
- Journal Title
  
  Int J Hematol
  
  Volume: 113 Issue: 1 Pages: 112-121
- DOI
  10.1007/s12185-020-02985-9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis.2021
- Author(s)
  Takakuwa T, Yamamura R, Ohta K, Kaneko H, Imada K, Nakaya A, Fuchida SI, Shibayama H, Matsuda M, Shimazu Y, Adachi Y, Kosugi S, Uchiyama H, Tanaka H, Hanamoto H, Shimura Y, Kanda J, Onda Y, Uoshima N, Yagi H, Yoshihara S, Hino M, Shimazaki C, Takaori-Kondo A, Kuroda J, Matsumura I, Kanakura Y, Nomura S.
- Journal Title
  
  Eur J Haematol
  
  Volume: 106 Issue: 4 Pages: 555-562
- DOI
  10.1111/ejh.13586
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-20K08743
[Journal Article] High numbers of programmed cell death-1-positive tumor infiltrating lymphocytes correlate with early onset of post-transplant lymphoproliferative disorder2021
- Author(s)
  Saito Hideaki、Miyoshi Hiroaki、Shibayama Hirohiko、Toda Jun、Kusakabe Shinsuke、Ichii Michiko、Fujita Jiro、Fukushima Kentaro、Maeda Tetsuo、Mizuki Masao、Oritani Kenji、Seto Masao、Yokota Takafumi、Kanakura Yuzuru、Hosen Naoki、Ohshima Koichi
- Journal Title
  
  International Journal of Hematology
  
  Volume: - Issue: 1 Pages: 53-64
- DOI
  10.1007/s12185-021-03129-3
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K17401, KAKENHI-PROJECT-19K08815, KAKENHI-PROJECT-19K08861
[Journal Article] Safety and Antitumor Activity of Acalabrutinib for Relapsed/Refractory B-cell Malignancies: A Japanese Phase I Study.2021
- Author(s)
  Izutsu K, Ando K, Ennishi D, Shibayama H, Suzumiya J, Yamamoto K, Ichikawa S, Kato K, Kumagai K, Patel P, Iizumi S, Hayashi N, Kawasumi H, Murayama K, Nagai H.
- Journal Title
  
  Cancer Sci
  
  Volume: 112 Issue: 6 Pages: 2405-2415
- DOI
  10.1111/cas.14886
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-19K07774
[Journal Article] Phase 2 Study of Tazemetostat for Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma with EZH2 Mutation in Japan.2021
- Author(s)
  Izutsu K, Ando K, Nishikori M, Shibayama H, Teshima T, Kuroda J, Kato K, Imaizumi Y, Nosaka K, Sakai R, Hojo S, Nakanishi T, Rai S.
- Journal Title
  
  Cancer Sci.
  
  Volume: 62 Issue: 7 Pages: 3627-3635
- DOI
  10.1111/cas.14937
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08818, KAKENHI-PROJECT-19K08861
[Journal Article] Graft-versus-host disease develops in mice transplanted with lymphocyte-depleted bone marrow cells from signal-transducing adaptor protein-2 transgenic mice2021
- Author(s)
  Saito H, Ichii M, Toda J, Kitai Y, Muromoto R, Kashiwakura JI, Saitoh K, Tanimura A, Yokota T, Shibayama H, Matsuda T, Oritani K, Kanakura Y, Hosen N.
- Journal Title
  
  Biochem Biophys Res Commun .
  
  Volume: 537 Pages: 118-124
- DOI
  10.1016/j.bbrc.2020.12.080
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08815, KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-19H03364, KAKENHI-PROJECT-18K08355
[Journal Article] A forodesine-based regimen as a therapeutic option for PTCL-NOS with Central nervous system involvement.2021
- Author(s)
  Doi Y, Yokota T, Shibayama H, Matsumoto K, Kurashige M, Nozaki K, Fujita J, Fukushima K, Hosen N.
- Journal Title
  
  Leuk Lymphoma
  
  Volume: 63 Issue: 4 Pages: 1013-1015
- DOI
  10.1080/10428194.2021.2005043
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Autonomous TGFβ signaling induces phenotypic variation in human acute myeloid leukemia2021
- Author(s)
  Yasuhiro Shingai , Takafumi Yokota，et al
- Journal Title
  
  Stem cells
  
  Volume: - Issue: 6 Pages: 723-736
- DOI
  10.1002/stem.3348
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K16356, KAKENHI-PROJECT-18K08355, KAKENHI-PROJECT-19K17622, KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-19K08863, KAKENHI-PROJECT-20K17378, KAKENHI-PROJECT-21K08415
[Journal Article] Oral ixazomib, lenalidomide, and dexamethasone for newly diagnosed transplant-ineligible multiple myeloma patients.2021
- Author(s)
  Facon T, Venner CP, Bahlis NJ, Offner F, White D, Karlin L, Benboubker L, Rigaudeau S, Rodon P, Voog E, Yoon SS, Suzuki K, Shibayama H, Zhang X, Twumasi-Ankrah P, Yung G, Rifkin RM, Moreau P, Lonial S, Kumar SK, Richardson PG, Rajkumar SV.
- Journal Title
  
  Blood
  
  Volume: 137 Issue: 26 Pages: 3616-3628
- DOI
  10.1182/blood.2020008787
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Carfilzomib, dexamethasone, and daratumumab in Asian patients with relapsed or refractory multiple myeloma: post hoc subgroup analysis of the phase 3 CANDOR trial.2021
- Author(s)
  Suzuki K, Min CK, Kim K, Lee JJ, Shibayama H, Ko PS, Huang SY, Li SS, Ding B, Khurana M, Iida S.
- Journal Title
  
  Int J Hematol
  
  Volume: 114 Issue: 6 Pages: 653-663
- DOI
  10.1007/s12185-021-03204-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: a prespecified subgroup analysis of high-risk patients from the ECHELON-1 study.2021
- Author(s)
  Hutchings M, Radford J, Ansell SM, Sureda A, Connors JM, Shibayama H, Abramson JS, Chua NS, Friedberg JW, LaCasce AS, Molina L, Engley G, Fenton K, Jolin H, Liu R, Gautam A, Gallamini A.
- Journal Title
  
  Hematol Oncol
  
  Volume: 39 Issue: 2 Pages: 185-195
- DOI
  10.1002/hon.2838
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease.2021
- Author(s)
  Konishi T, Kusakabe S, Hino A, Inamoto K, Yoshifuji K, Kiridoshi Y, Takeshita K, Sasajima S, Toya T, Igarashi A, Najima Y, Kobayashi T, Doki N, Motooka D, Nakamura S, Suyama M, Suda W, Shiota A, Atarashi K, Hattori M, Honda K, Yokota T, Ohashi K, Shibayama H, Fukushima K, Kakihana K.
- Journal Title
  
  Bone Marrow Transplant
  
  Volume: 56 Issue: 7 Pages: 1728-1731
- DOI
  10.1038/s41409-021-01249-2
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-20K17401
[Journal Article] Phase II study of tazemetostat for relapsed or refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan.2021
- Author(s)
  Izutsu K, Ando K, Nishikori M, Shibayama H, Teshima T, Kuroda J, Kato K, Imaizumi Y, Nosaka K, Sakai R, Hojo S, Nakanishi T, Rai S.
- Journal Title
  
  Cancer Sci
  
  Volume: 112 Issue: 9 Pages: 3627-3635
- DOI
  10.1111/cas.15040
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Curative potential of fludarabine, melphalan, and non-myeloablative dosage of busulfan in elderly patients with myeloid malignancy2020
- Author(s)
  Tomoaki Ueda, Tomoyasu Jo, Kazuya Okada, Yasuyuki Arai, Takayuki Sato, Takeshi Maeda, Tatsuhito Onishi, Yasunori Ueda
- Journal Title
  
  Int J Hematol
  
  Volume: 111 Issue: 2 Pages: 247-255
- DOI
  10.1007/s12185-019-02763-2
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08863, KAKENHI-PROJECT-18K08326
[Journal Article] Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.2020
- Author(s)
  Fukuhara N, Yamamoto G, Tsujimura H, Chou T, Shibayama H, Yanai T, Shibuya K, Izutsu K.
- Journal Title
  
  Leukemia and Lymphoma
  
  Volume: 61 Issue: 1 Pages: 176-180
- DOI
  10.1080/10428194.2019.1654100
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Enterococcus: A predictor of ravaged microbiota and poor prognosis after allogeneic hematopoietic stem cell transplantation.2020
- Author(s)
  Kusakabe S, Fukushima K, Yokota T, Hino A, Fujita J, Motooka D, Nakamura S, Shibayama H, Kanakura Y.
- Journal Title
  
  Biol Blood Marrow Transplant
  
  Volume: 26 Issue: 5 Pages: 1028-1033
- DOI
  10.1016/j.bbmt.2020.01.019
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-20K17401, KAKENHI-PROJECT-18K08355
[Journal Article] A Multi-Center Retrospective Analysis of Patients With Relapsed/Refractory Follicular Lymphoma After Third-Line Chemotherapy.2020
- Author(s)
  Fuji S, Tada Y, Nozaki K, Saito H, Ozawa T, Kida T, Kosugi S, Sugahara H, Ikeda H, Hashimoto K, Karasuno T, Ueda S, Ishikawa J, Shibayama H.
- Journal Title
  
  Ann Hematol
  
  Volume: 99 Issue: 9 Pages: 2133-2139
- DOI
  10.1007/s00277-020-04126-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR.2020
- Author(s)
  Takezako N, Shibayama H, Handa H, Hagiwara S, Ozaki S, Suzuki K, Kosugi H, Ri M, Sugiura I, Choi I, Miyamoto T, Iida S.
- Journal Title
  
  Int J Hematol
  
  Volume: 113 Issue: 2 Pages: 219-230
- DOI
  10.1007/s12185-020-03013-6
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Limbic encephalitis with antibodies to N-methyl-D-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation.2020
- Author(s)
  Toda J, Maeda T, Akuta K, Kusakabe S, Ueda T, Fujita J, Shibayama H, Oritani K, Takahashi Y, Kanakura Y.
- Journal Title
  
  Int J Hematol
  
  Volume: 112 Issue: 2 Pages: 254-257
- DOI
  10.1007/s12185-020-02859-0
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-18K07865
[Journal Article] Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML.2020
- Author(s)
  Toda J, Ichii M, Oritani K, Shibayama H, Tanimura A, Saito H, Yokota T, Motooka D, Okuzaki D, Kitai Y, Muromoto R, Kashiwakura JI, Matsuda T, Hosen N, Kanakura Y.
- Journal Title
  
  Oncogene
  
  Volume: 39 Issue: 34 Pages: 5601-5615
- DOI
  10.1038/s41388-020-01387-9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-20K08356, KAKENHI-PROJECT-19H03364, KAKENHI-PROJECT-20H03710, KAKENHI-PROJECT-18K08355, KAKENHI-PROJECT-19K17829
[Journal Article] Signal-transducing adaptor protein-2 delays recovery of B lineage lymphocytes during hematopoietic stress2020
- Author(s)
  Ichii Michiko、Oritani Kenji、Toda Jun、Saito Hideaki、Shi Henyun、Shibayama Hirohiko、Motooka Daisuke、Kitai Yuichi、Muromoto Ryuta、Kashiwakura Jun-ichi、Saitoh Kodai、Okuzaki Daisuke、Matsuda Tadashi、Kanakura Yuzuru
- Journal Title
  
  Haematologica
  
  Volume: in press Issue: 2 Pages: 225573-225573
- DOI
  10.3324/haematol.2019.225573
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08815, KAKENHI-PROJECT-18K14893, KAKENHI-PROJECT-19H03364, KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-19K17829
[Journal Article] Daratumumab, lenalidomide, and dexamethasone in Japanese patients with transplant-ineligible newly diagnosed multiple myeloma: a phase 1b study.2020
- Author(s)
  Takamatsu H, Iida S, Shibayama H, Shibayama K, Yamazaki H, Suzuki K.
- Journal Title
  
  Int J Hematol
  
  Volume: 115 Issue: 5 Pages: 692-701
- DOI
  10.1007/s12185-020-02825-w
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib on Pulmonary Hypertension and the Cardiac Function in a Patient with Myelofibrosis2020
- Author(s)
  Miyawaki H, Kioka H, Sato K, Kurashige M, Ozawa T, Shibayama H, Hikoso S, Morii E, Yamauchi-Takihara K, Sakata Y.
- Journal Title
  
  Intern. Med.
  
  Volume: 59 Issue: 2 Pages: 229-233
- DOI
  10.2169/internalmedicine.3528-19
- NAID
  130007785096
- ISSN
  0918-2918, 1349-7235
- Year and Date
  2020-01-15
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-18K19543, KAKENHI-PROJECT-19K16585
[Journal Article] A Multicenter, Open-Label, Phase II Study of Tirabrutinib (ONO/GS-4059) in Patients With Waldenstrom's Macroglobulinemia.2020
- Author(s)
  Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Shiibashi R, Izutsu K.
- Journal Title
  
  Cancer Sci
  
  Volume: 111 Issue: 9 Pages: 3327-3337
- DOI
  10.1111/cas.14561
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function.2020
- Author(s)
  Yasuhiro Nagate, Sachiko Ezoe, Jiro Fujita, Daisuke Okuzakis, Daisuke Motooka, Tomohiko Ishibashi, Michiko Ichii, Akira Tanimura, Masako Kurashige, Eiichi Morii, Takuya Fukushima, Youko Suehiro, Takafumi Yokota, Hirohiko Shibayama, Kenji Oritani, Yuzuru Kanakura
- Journal Title
  
  Leukemia
  
  Volume: － Issue: 1 Pages: 107-118
- DOI
  10.1038/s41375-020-0788-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17622, KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-18K08355, KAKENHI-PROJECT-19K16585
[Journal Article] Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial2020
- Author(s)
  Kimura Shinya、Imagawa Jun、Murai Kazunori、Hino Masayuki、Kitawaki Toshio、Okada Masaya、Tanaka Hideo、Shindo Motohiro、Kumagai Takashi、Ikezoe Takayuki、Uoshima Nobuhiko、Sato Tsutomu、Watanabe Reiko、Kowata Shugo、Hayakawa Masaya、Hosoki Takaaki、Ikeda Kazuhiko、et al.
- Journal Title
  
  The Lancet Haematology
  
  Volume: 7 Issue: 3 Pages: 218-225
- DOI
  10.1016/s2352-3026(19)30235-2
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08365, KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-17K09908, KAKENHI-PROJECT-20K08756, KAKENHI-PROJECT-19K17860
[Journal Article] Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma.2020
- Author(s)
  Nozaki K, Sugahara H, Ueda S, Ishikawa J, Fuji S, Masaie H, Tada Y, Karasuno T, Iida M, Mitsui H, Kamae T, Saito N, Moriyama Y, Kawakami M, Kato R, Nakae Y, Kida T, Kosugi S, Nakagawa M, Uchida Y, Azenishi Y, Sakaniwa R, Kitamura T, Shibayama H.
- Journal Title
  
  Leukemia and Lymphoma
  
  Volume: 61 Issue: 9 Pages: 2113-2121
- DOI
  10.1080/10428194.2020.1759054
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, Phase 1/2, safety and efficacy study.2020
- Author(s)
  Sunami K, Suzuki K, Ri M, Matsumoto M, Shimazaki C, Asaoku H, Shibayama H, Ishizawa K, Takamatsu H, Ikeda T, Maruyama D, Kaneko H, Uchiyama M, Kiguchi T, Iyama S, Murakami H, Takahashi K, Tada K, S, Guillemin-Paveau H, Iida S.
- Journal Title
  
  Cancer Sci
  
  Volume: 111 Issue: 12 Pages: 4526-4539
- DOI
  10.1111/cas.14657
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Clinical utility of target capture‐based panel sequencing in hematological malignancies: A multicenter feasibility study2020
- Author(s)
  Yasuda T, Sanada M, Nishijima D, Kanamori T, Iijima Y, Hattori H, Saito A, Miyoshi H, Ishikawa Y, Asou N, Usuki K, Hirabayashi S, Kato M, Abe M.
- Journal Title
  
  Cancer Science
  
  Volume: 111 Issue: 9 Pages: 3367-3378
- DOI
  10.1111/cas.14552
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-20K08723, KAKENHI-PROJECT-20K08759, KAKENHI-PROJECT-19H05656
[Journal Article] Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.2020
- Author(s)
  Nakaya A, Tanaka H, Yagi H, Ohta K, Shibayama H, Kohara T, Kanda J, Shindo M, Shimura Y, Kosugi S, Kaneko H, Fuchida SI, Uoshima N, Shimazaki C, Hino M, Kuroda J, Kanakura Y, Takaori-Kondo A, Nomura S, Matsumura I; Kansai Myeloma Forum Investigators.
- Journal Title
  
  Int J Hematol
  
  Volume: 112 Issue: 5 Pages: 666-673
- DOI
  10.1007/s12185-020-02961-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-20K08743
[Journal Article] Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry.2020
- Author(s)
  Nakaya A, Kohara T, Shibayama H, Onda Y, Kanda J, Kaneko H, Kosugi S, Ishikawa J, Tanaka H, Fuchida SI, Shimura Y, Ohta K, Shimazaki C, Hino M, Takaori-Kondo A, Kuroda J, Matsumura I, Kanakura Y, Nomura S; Kansai Myeloma Forum Investigators.
- Journal Title
  
  Int J Hematol
  
  Volume: 112 Issue: 4 Pages: 435-438
- DOI
  10.1007/s12185-020-02996-6
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-20K08743
[Journal Article] Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation.2020
- Author(s)
  Kusakabe S, Fukushima K, Maeda T, Motooka D, Nakamura S, Fujita J, Yokota T, Shibayama H, Oritani K, Kanakura Y.
- Journal Title
  
  Br J Haematol
  
  Volume: 188 Issue: 3 Pages: 438-449
- DOI
  10.1111/bjh.16205
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-20K17401
[Journal Article] Whole-exome sequencing identified mutational profile of a case with T-cell chronic lymphocytic leukemia.2020
- Author(s)
  Nozaki K, Yokota T, Itotagawa E, Tsutsumi K, Kusakabe S, Morikawa Y, Fujita J, Fukushima K, Maeda T, Shibayama H, Hosen N, Kumanogo A, Kanakura Y.
- Journal Title
  
  Clin Case Rep
  
  Volume: 8 Issue: 11 Pages: 2251-2254
- DOI
  10.1002/ccr3.3149
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Phase I study of ibrutinib in Japanese patients with treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma.2019
- Author(s)
  Shibayama H, Teshima T, Choi I, Hataka K, Sekiguchi N, Yoshinari N.
- Journal Title
  
  J Clin Exp Hematopathology
  
  Volume: 59 Issue: 4 Pages: 179-186
- DOI
  10.3960/jslrt.19023
- NAID
  130007771350
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-17K09903
[Journal Article] Endothelial Cell-Selective Adhesion Molecule Contributes to the Development of Definitive Hematopoiesis in the Fetal Liver2019
- Author(s)
  Ueda Tomoaki、Yokota Takafumi、Okuzaki Daisuke、Uno Yoshihiro、Mashimo Tomoji、Kubota Yoshiaki、Sudo Takao、Ishibashi Tomohiko、Shingai Yasuhiro、Doi Yukiko、Ozawa Takayuki、Nakai Ritsuko、Tanimura Akira、Ichii Michiko、Ezoe Sachiko、Shibayama Hirohiko、Oritani Kenji、Kanakura Yuzuru
- Journal Title
  
  Stem Cell Reports
  
  Volume: 13 Issue: 6 Pages: 992-1005
- DOI
  10.1016/j.stemcr.2019.11.002
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08355, KAKENHI-PROJECT-19K08861, KAKENHI-PROJECT-19K08863, KAKENHI-PROJECT-19K17622, KAKENHI-PROJECT-18KK0307, KAKENHI-PROJECT-18H03974, KAKENHI-PROJECT-18K16114
[Journal Article] Additional validation of Osaka method (0.01 mol/L dithiothreitol) for negating the daratumumab interference.2019
- Author(s)
  Hosokawa M, Kashiwagi H, Nakayama K, Sakuragi M, Nakao M, Morikawa T, Kiyokawa T, Aochi H, Nagamine K, Shibayama H, Tomiyama Y.
- Journal Title
  
  Transfusion.
  
  Volume: 59 Issue: 7 Pages: 2479-2480
- DOI
  10.1111/trf.15305
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08326, KAKENHI-PROJECT-19K08813, KAKENHI-PROJECT-19K08861
[Journal Article] Unexpected complication of R-CHOP chemotherapy: Rapidly progressive bronchiolitis obliterans syndrome.2019
- Author(s)
  Nozaki K, Ezoe S, Hamaguchi M, Tsutsumi K, Kusakabe S, Morikawa Y, Fujita J, Fukushima K, Maeda T, Shibayama H, Kumanogo A, Kanakura Y.
- Journal Title
  
  Eur J Case Rep Intern Med
  
  Volume: 6 Issue: 11 Pages: 001266-001266
- DOI
  10.12890/2019_001266
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study.2019
- Author(s)
  Iida S, Watanabe T, Matsumoto M, Suzuki K, Sunami K, Ishida T, Ando K, Chou T, Ozaki S, Taniwaki M, Uike N, Shibayama H, Hatake K, Izutsu K, Ishikawa T, Shumiya Y, Tobinai K.
- Journal Title
  
  Cancer Sci
  
  Volume: 110 Issue: 9 Pages: 2924-2932
- DOI
  10.1111/cas.14139
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08861
[Journal Article] Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single-arm phase 2 trial2018
- Author(s)
  Morita Yasuyoshi、Maeda Yasuhiro、Yamaguchi Terufumi、Urase Fumiaki、Kawata Shuhei、Hanamoto Hitoshi、Tsubaki Kazuo、Ishikawa Jun、Shibayama Hirohiko、Matsumura Itaru、Matsuda Mitsuhiro
- Journal Title
  
  Cancer Science
  
  Volume: 109 Issue: 10 Pages: 3209-3215
- DOI
  10.1111/cas.13739
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08375, KAKENHI-PROJECT-16K09871
[Journal Article] Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial)2018
- Author(s)
  Ishikawa Jun、Matsumura Itaru、Kawaguchi Tatsuya、Kuroda Junya、Nakamae Hirohisa、Miyamoto Toshihiro、Matsuoka Ken-ichi、Shibayama Hirohiko、Hino Masayuki、Hirase Chikara、Kamimura Tomohiko、Shimose Takayuki、Akashi Koichi、Kanakura Yuzuru
- Journal Title
  
  International Journal of Hematology
  
  Volume: 107 Issue: 5 Pages: 535-540
- DOI
  10.1007/s12185-018-2401-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K08375, KAKENHI-PROJECT-16K09871
[Journal Article] Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma2018
- Author(s)
  Maruyama Dai、Tsukasaki Kunihiro、Uchida Toshiki、Maeda Yoshinobu、Shibayama Hirohiko、Nagai Hirokazu、Hatake Kiyohiko、Ando Kiyoshi、Yoshida Isao、Taniwaki Masafumi、Suzumiya Junji、Tamura Kazuo、Yamauchi Takahiro、Ueda Ryuzo、Tobinai Kensei
- Journal Title
  
  Annals of Hematology
  
  Volume: 98 Issue: 1 Pages: 131-142
- DOI
  10.1007/s00277-018-3418-2
- Data Source
  KAKENHI-PROJECT-16K09871
[Journal Article] Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum2018
- Author(s)
  Matsumura-Kimoto Y, Kuroda J, Kaneko H, Kamitsuji Y, Fuchida SI, Nakaya A, Shibayama H, Uoshima N, Yokota I, Uchiyama H, Yagi H, Kosugi S, Matsui T, Ishikawa J, Matsuda M, Ohta K, Iida M, Tanaka H, Kobayashi M, Wada K, Shimazaki C, Nomura S, Imada K, Hino M, Matsumura I, Kanakura Y, Takaori-Kondo A; KMF
- Journal Title
  
  International Journal of Hematology
  
  Volume: 107 Issue: 5 Pages: 541-550
- DOI
  10.1007/s12185-018-2416-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08375, KAKENHI-PROJECT-16K09862, KAKENHI-PROJECT-16K09871
[Journal Article] Distinct effects of daratumumab on indirect and direct antiglobulin tests: a new method employing 0.01 mol/L dithiothreitol for negating the daratumumab interference with preserving K antigenicity (Osaka method).2018
- Author(s)
  Hosokawa M, Kashiwagi H, Nakayama K, Sakuragi M, Nakao M, Morikawa T, Kiyokawa T, Aochi H, Nagamine K, Shibayama H, Tomiyama Y.
- Journal Title
  
  Transfusion
  
  Volume: 58 Issue: 12 Pages: 3003-3013
- DOI
  10.1111/trf.14900
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K08326, KAKENHI-PROJECT-16K09826, KAKENHI-PROJECT-16K09871
[Journal Article] Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment2018
- Author(s)
  Okada M, Imagawa J, et al.
- Journal Title
  
  Clin Lymphoma Myeloma Leuk.
  
  Volume: 18 Issue: 5 Pages: 353-360
- DOI
  10.1016/j.clml.2018.03.004
- NAID
  120006463738
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K07185, KAKENHI-PROJECT-17K07142, KAKENHI-PROJECT-17K09908, KAKENHI-PROJECT-17K09953, KAKENHI-PROJECT-16K09871
[Journal Article] Identification of MS4A3 as a reliable marker for early myeloid differentiation in human hematopoiesis.2018
- Author(s)
  Ishibashi T, Yokota T, Satoh Y, Ichii M, Sudo T, Doi Y, Ueda T, Nagate Y, Hamanaka Y, Tanimura A, Ezoe S, Shibayama H, Oritani K, Kanakura Y.
- Journal Title
  
  Biochemical and Biophysical Research Communications
  
  Volume: 495 Issue: 3 Pages: 2338-2343
- DOI
  10.1016/j.bbrc.2017.12.117
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K16201, KAKENHI-PROJECT-16H05339, KAKENHI-PROJECT-15K09475, KAKENHI-PROJECT-17K09903, KAKENHI-PROJECT-16K09871, KAKENHI-PROJECT-16K09874
[Journal Article] Variable SATB1 Levels Regulate Hematopoietic Stem Cell Heterogeneity with Distinct Lineage Fate2018
- Author(s)
  Yukiko Doi, Takafumi Yokota, Yusuke Satoh, Daisuke Okuzaki, Masahiro Tokunaga, Tomohiko Ishibashi, Takao Sudo, Tomoaki Ueda, Yasuhiro Shingai, Michiko Ichii, Akira Tanimura, Sachiko Ezoe, Hirohiko Shibayama, Terumi Kohwi-Shigematsu, Junji Takeda, Kenji Oritani, and Yuzuru Kanakura
- Journal Title
  
  Cell Reports
  
  Volume: 23 Issue: 11 Pages: 3223-3235
- DOI
  10.1016/j.celrep.2018.05.042
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09952, KAKENHI-PROJECT-18K08355, KAKENHI-PROJECT-16H05339, KAKENHI-PROJECT-16K09871, KAKENHI-PROJECT-16K09872, KAKENHI-PROJECT-16K09874, KAKENHI-PROJECT-18K19445, KAKENHI-PROJECT-17K16201
[Journal Article] Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry2018
- Author(s)
  Nakaya A, Yagi H, Kaneko H, Kosugi S, Kida T, Adachi Y, Shibayama H, Kohara T, Kamitsuji Y, Fuchida SI, Uoshima N, Kawata E, Uchiyama H, Shimura Y, Takahashi T, Urase F, Ohta K, Hamada T, Miyamoto K, Kobayashi M, Shindo M, Tanaka H, Shimazaki C, Hino M, Kuroda J, Kanakura Y, Takaoari-Kondo A, Nomura S, Matsumura I
- Journal Title
  
  Leukemia Research Reports
  
  Volume: 10 Pages: 7-10
- DOI
  10.1016/j.lrr.2018.07.001
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08375, KAKENHI-PROJECT-16K09862, KAKENHI-PROJECT-16K09871
[Journal Article] ESAM is a novel human hematopoietic stem cell marker associated with a subset of human leukemias.2016
- Author(s)
  Ishibashi T, Yokota T, Tanaka H, Ichii M, Sudo T, Satoh Y, Doi Y, Ueda T, Tanimura A, Hamanaka Y, Ezoe S, Shibayama H, Oritani K, Kanakura Y.
- Journal Title
  
  Experimental Hematology
  
  Volume: 44 Issue: 4 Pages: 269-281
- DOI
  10.1016/j.exphem.2015.12.010
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-15K09475, KAKENHI-PROJECT-26461412, KAKENHI-PROJECT-26461446, KAKENHI-PROJECT-25461418, KAKENHI-PROJECT-25461439, KAKENHI-PROJECT-16H05339, KAKENHI-PROJECT-15H06373, KAKENHI-PROJECT-26461420, KAKENHI-PROJECT-26461444, KAKENHI-PROJECT-15K09461, KAKENHI-PROJECT-16K09862, KAKENHI-PROJECT-16K09872
[Journal Article] A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes2015
- Author(s)
  Jang JH, Harada H, Shibayama H, Shimazaki R, Kim HJ, Sawada K, Mitani K
- Journal Title
  
  Int J Hematol
  
  Volume: 102(4) Issue: 4 Pages: 401-412
- DOI
  10.1007/s12185-015-1862-5
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09460, KAKENHI-PROJECT-15H03137, KAKENHI-PROJECT-25461422, KAKENHI-PROJECT-25461449
[Journal Article] Quantitative polymerase chain reaction analysis with allele-specific oligonucleotide primers for individual IgH VDJ regions to evaluate tumor burden in myeloma patients.2015
- Author(s)
  Sata H, Shibayama H, Maeda I, Habuchi Y, Nakatani E, Fukushima K, Fujita J, Ezoe S, Tadokoro S, Maeda T, Mizuki M, Kosugi S, Nakagawa M, Ueda S, Iida M, Tokumine Y, Azenishi Y, Mitsui H, Oritani K, Kanakura Y.
- Journal Title
  
  Exp Hematol.
  
  Volume: 印刷中 Issue: 5 Pages: 374-381
- DOI
  10.1016/j.exphem.2015.01.002
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25461419, KAKENHI-PROJECT-25461449, KAKENHI-PROJECT-25461450, KAKENHI-PROJECT-25293220
[Journal Article] The anti-apoptotic gene Anamorsin is essential for both autonomous and extrinsic regulation of murine fetal liver hematopoiesis.2014
- Author(s)
  Tanimura A, Shibayama H, Hamanaka Y, Fujita N, Ishibashi T, Sudo T, Yokota T, Ezoe S, Tanaka H, Matsumura I, Oritani K, Kanakura Y.
- Journal Title
  
  Exp Hematol.
  
  Volume: 42 Issue: 5 Pages: 410-422
- DOI
  10.1016/j.exphem.2014.01.002
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PUBLICLY-25130712, KAKENHI-PROJECT-25293220, KAKENHI-PROJECT-25461416, KAKENHI-PROJECT-25461439, KAKENHI-PROJECT-25461449, KAKENHI-PROJECT-26461401, KAKENHI-PROJECT-26461412
[Journal Article] The preventative effects of recombinant thrombomodulin on transplantation- associated coagulopathy after allogeneic hematopoietic stem cell transplantation2014
- Author(s)
  Nomura S, Ishii K, Maeda Y, Katayama Y, Yagi H, Fujishima N, Ota S, Seki M, Okada M, Ikezoe T, Hayashi K, Fujita S, Satake A, Ito T, Kyo T, Ishida Y, Chiba S, Ogawa H, Tanimoto M, Sawada K
- Journal Title
  
  Journal of Stem Cell Research & Therapy
  
  Volume: 4 Issue: 1 Pages: 247-247
- DOI
  10.1007/s12185-014-1696-6
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24591434, KAKENHI-PUBLICLY-25130712, KAKENHI-PROJECT-15K09461, KAKENHI-PROJECT-25461439, KAKENHI-PROJECT-25461449, KAKENHI-PROJECT-25293220
[Journal Article] Anamorsin, a novel caspase-3 substrate in neurodegeneration.2014
- Author(s)
  Yun N, Lee YM, Kim C, Shibayama H, Tanimura A, Hamanaka Y, Kanakura Y, Park IS, Jo A, Shin JH, Ju C, Kim WK, Oh YJ.
- Journal Title
  
  J Biol Chem
  
  Volume: 289 Issue: 32 Pages: 22183-22195
- DOI
  10.1074/jbc.m114.552679
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25293220, KAKENHI-PROJECT-25461449, KAKENHI-PROJECT-26461401
[Journal Article] Caspase-3-mediated cleavage of PICOT in apoptosis2013
- Author(s)
  Yun N, Kim C, Cha H, Park WJ, ShibayamaH, Park I-S, Oh YJ
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 432 Pages: 533-538
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.2013
- Author(s)
  Ueda Y
- Journal Title
  
  Leukemia & Lymphoma
  
  Volume: 未定 Issue: 7 Pages: 1450-1458
- DOI
  10.3109/10428194.2012.745074
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24249055, KAKENHI-PROJECT-24659457, KAKENHI-PROJECT-25293220, KAKENHI-PROJECT-25461449, KAKENHI-PUBLICLY-23130503
[Journal Article] Prognosis of core-binding factor acute myeloid leukemia after first relapse.2013
- Author(s)
  Kurosawa S, Miyawaki S, Yamaguchi T, Kanamori H, Sakura T, Moriuchi Y, Sano F, Kobayashi T, Yasumoto A, Hatanaka K, Yanada M, Nawa Y, Takeuchi J, Nakamura Y, Fujisawa S, Shibayama H, Miura I, Fukuda T.
- Journal Title
  
  Haematologica
  
  Volume: 98 Issue: 10 Pages: 1523-1531
- DOI
  10.3324/haematol.2012.078030
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25461449
[Journal Article] The Endothelial Antigen ESAM Monitors Hematopoietic Stem Cell Status between Quiescence and Self-Renewal.2012
- Author(s)
  Sudo, T.
- Journal Title
  
  J. Immunol.
  
  Volume: 189 Issue: 1 Pages: 200-210
- DOI
  10.4049/jimmunol.1200056
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390096, KAKENHI-PROJECT-22390194, KAKENHI-PROJECT-22591034, KAKENHI-PROJECT-22591035, KAKENHI-PROJECT-22591062, KAKENHI-PUBLICLY-23111536, KAKENHI-PROJECT-23591385, KAKENHI-PROJECT-23591387, KAKENHI-PUBLICLY-23118514, KAKENHI-ORGANIZER-24111001, KAKENHI-PLANNED-24111003
[Journal Article] The endothelial antigen ESAM monitors hematopoietic stem cell status between quiescence and self-renewal2012
- Author(s)
  Sudo T, Yokota T, Oritani K, Satoh Y, Sugiyama T, Ishida T, Shibayama H, Ezoe S, Fujita N, Tanaka H, Maeda T, Nagasawa T, Kanakura Y.
- Journal Title
  
  J Immunol
  
  Volume: 189 Pages: 200-210
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] The endothelial antigen ESAM monitors hematopoietic stem cell status between quiescence and self-renewal2012
- Author(s)
  Sudo T, Yokota T, Oritani K, Satoh Y, Sugiyama T, Ishida T, Shibayama H, Ezoe S, Fujita N, Tanaka H, Maeda T, Nagasawa T, Kanakura Y
- Journal Title
  
  J Immunol
  
  Volume: 189 Pages: 200-210
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390194
[Journal Article] Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: A multicenter validation study2012
- Author(s)
  Ogata K, Kakumoto K, Matsuda A, Tohyama K, Tamura H, Ueda Y, Kurokawa M, Takeuchi J, Shibayama H, Emi N, Motoji T, Miyazaki Y, Tamaki H, Mitani K, Naoe T, Sugiyama H, Takaku F
- Journal Title
  
  Leuk Res
  
  Volume: 36 Pages: 1229-1236
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era2012
- Author(s)
  Tomita N, Yokoyama M, Yamamoto W, Watanabe R, Shimazu Y, Masaki Y, Tsunoda S, Hashimoto C, Murayama K, Yano T, Okamoto R, Kikuchi A, Tamura K, Sato K, Sunami K, Shibayama H, Takimoto R, Oshima R, Hatta Y, Moriuchi Y, Kinoshita T, Yamamoto M, Numata A, Ish
- Journal Title
  
  Cancer Sci
  
  Volume: 103 Pages: 245-251
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] A cell-death-defying factor, anamorsin mediates cell growth through inactivation of PKC and p38MAPK.2011
- Author(s)
  Saito Y, Shibayama H, et al.
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 405 Pages: 303-307
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] Nuclear translocation of anamorsin during drug-induced dopaminergic neurodegeneration in culture and in rat brain.2011
- Author(s)
  Park KA, Shibayama H, et al.
- Journal Title
  
  J Neural Transm
  
  Volume: (印刷中)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] PICOT is a molecule which binds to anamorsin2011
- Author(s)
  Saito Y, Shibayama H, Tanaka H, Tanimura A, et al
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 408 Pages: 329-333
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] Predictability of the response to tyrosine kinase inhibitors via in vitro analysis of Bcr-Abl phosphorylation2011
- Author(s)
  Shibayama M, Ezoe S, Matsumura I, et al.(他8名、11番目)
- Journal Title
  
  Leukemia Research
  
  Volume: 35 Pages: 1025-1211
- URL
  http://www.sciencedirect.com/science/article/pii/S0145212611000221
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22659180
[Journal Article] PICOT is a molecule which binds to anamorsin2011
- Author(s)
  Saito Y, Shibayama H, Tanaka H, Tanimura A, Matsumura I, Kanakura Y, et al
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 408(2) Pages: 329-333
- URL
  http://dx.doi.org/10.1016/j.bbrc.2011.04.033
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591202
[Journal Article] A cell-death-defying factor, anamorsin mediates cell growth through inactivation of PKC and p38MAPK2011
- Author(s)
  Saito Y, Shibayama H, Tanaka H, Tanimura A, Kanakura Y.
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 405 Pages: 303-307
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] A cell-death-defying factor, anamorsin mediates cell growth through inactivation of PKC and p38MAPK.2011
- Author(s)
  Saito Y, Shibayama H, Kanakura Y, et al.
- Journal Title
  
  Biochem Biophys Res Commun.
  
  Volume: 405(2) Pages: 303-307
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390194
[Journal Article] Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma2011
- Author(s)
  Zaki M, Wada N, Ikeda J, Shibayama H, Hashimoto K, Yamagami T, Tatsumi Y, Tsukaguchi M, Morii E, Aozasa K
- Journal Title
  
  Virchows Archiv
  
  Volume: 459 Pages: 361-366
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] PICOT is a molecule which binds to anamorsin.2011
- Author(s)
  Saito Y, Shibayama H, Tanaka H, et al.
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 408 Pages: 329-333
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591387
[Journal Article] PICOT is a molecule which binds to anamorsin2011
- Author(s)
  Saito Y, Shibayama H, Tanaka H, Tanimura A, Matsumura I, Kanakura Y
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 408 Issue: 2 Pages: 329-333
- DOI
  10.1016/j.bbrc.2011.04.033
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591387
[Journal Article] PICOT is a molecule which binds to anamorsin2011
- Author(s)
  Saito Y, Shibayama H, Tanaka H, Tanimura A, Matsumura I, Kanakura Y
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 408 Pages: 329-333
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390194
[Journal Article] A cell-death-defying factor, anamorsin mediates cell growth through inactivation of PKC and p38MAPK2011
- Author(s)
  Saito Y, Shibayama H, Tanaka H, Tanimura A, Kanakura Y
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 405 Pages: 303-307
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390194
[Journal Article] Oh YJ. Nuclear translocation of anamorsin during drug-induced dopaminergic neurodegeneration in culture and in rat brain2011
- Author(s)
  Park KA, Yun N, Shin DI, Choi SY, Kim H, Kim WK, Kanakura Y, Shibayama H
- Journal Title
  
  J Neural Transm
  
  Volume: 118 Pages: 433-444
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] PICOT is a molecule which binds to anamorsin.2011
- Author(s)
  Saito Y, Shibayama H, Tanaka H, Tanimura A, Matsumura I, Kanakura Y.
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 408 Pages: 329-333
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] for the Japanese AMN107/2303 Study Group. Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloidleukemia in chronic phase: results from the Japanese subgroup of ENESTnd2011
- Author(s)
  Nakamae H, Shibayama H, Kurokawa M, Fukuda T, Nakaseko C, Kanda Y, Nagai T, Ohnishi K, Maeda M, Matsuda A, Amagasaki T, Yanada M
- Journal Title
  
  Int J Hematol
  
  Volume: 93 Pages: 624-632
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd2011
- Author(s)
  Nakamae H, Shibayama H, Kurokawa M, Fukuda T, et al
- Journal Title
  
  Int J Hematol
  
  Volume: 93 Pages: 624-632
- NAID
  10029535125
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] Peripheral T-cell lymphoma of Lennert type complicated by monoclonal proliferation of lrge B-cells.2010
- Author(s)
  Chihara T, Shibayama H, Kanakura Y, et al.
- Journal Title
  
  Pathol Res Pract.
  
  Volume: 206 Pages: 185-190
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390194
[Journal Article] Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse.2010
- Author(s)
  Kurosawa S, Shibayama H, et al.
- Journal Title
  
  Haematologica.
  
  Volume: 95 Pages: 1857-1864
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390194
[Journal Article] Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse2010
- Author(s)
  Kurosawa S, Yamaguchi T, Miyawaki S, Uchida N, Sakura T, Kanamori H, Usuki K, Yamashita T, Okoshi Y, Shibayama H, Nakamae H, Mawatari M, Hatanaka K,Sunami K, Shimoyama M, Fujishima N, Maeda Y, Miura I, Takaue Y, Fukuda T
- Journal Title
  
  Haematologica
  
  Volume: 95 Pages: 1857-1864
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] Peripheral T-cell lymphoma of Lennert type complicated by monoclonal proliferation of large B-cells2010
- Author(s)
  Chihara T, Wada N, Kohara M, Matsui T, Masaya H, Maeda T, Shibayama H, Kanakura Y, Tani M, Morii E, Aozasa K.
- Journal Title
  
  Pathol Res Pract
  
  Volume: 206 Pages: 185-190
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591034
[Journal Article] AML1/RUNX1 works as a negative regulator of c-Mpl in hematopoietic stem cells2008
- Author(s)
  Satoh Y, Matsumura I, Tanaka H, Ezoe S, Fukushima K, Tokunaga M, Yasumi M, Shibayama H, Mizuki M, Era T, Okuda T, Kanakura Y
- Journal Title
  
  J Biol Chem 283
  
  Pages: 30045-30056
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591108
[Journal Article] The expression of anamorsin in diffuse large B cell lymphoma : Possible prognostic biomarkaer for low IPI patients2008
- Author(s)
  Shizusawa T, Shibayama H, Murata S, Saitoh Y, Sugimoto Y, Matsumura I, Ogawa H, Sugiyama H, Fukuhara S, Hino M, Kanamaru A, Yamauchi A, Aozasa K, Kanakura Y.
- Journal Title
  
  Leuk Lymphoma 49
  
  Pages: 113-121
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591108
[Journal Article] The expression of anamorsin in diffuse large B cell lymphoma : possible prognostic biomarker for low IPI patients.2008
- Author(s)
  Shizusawa T, Shibayama H, Matsumura I, et al., 他
- Journal Title
  
  Leuk Lymphoma. 49
  
  Pages: 113-121
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20390269
[Journal Article] 抗死分子アナモルシンとリンパ系腫瘍2008
- Author(s)
  柴山浩彦
- Journal Title
  
  臨床血液 49
  
  Pages: 234-239
- NAID
  10021257481
- Data Source
  KAKENHI-PROJECT-19591108
[Journal Article] Checkpoint apoptosis uncoupling in human and mouse embryonic stem cells : a source of karyotypic instability2007
- Author(s)
  Mantel C, Guo Y, Lee MR, Kim MK, Han MK, Shibayama H, Fukuda S, Yoder MC, Pelus LM, Kim KS, Broxmeyer HE
- Journal Title
  
  Blood 109
  
  Pages: 4518-4527
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591108
[Journal Article] Roles of tyrosine residues 845, 892 and 922 in constitutive activation of murine FLT3 kinase domain mutant.2005
- Author(s)
  Ishiko J, Mizuki M, Shibayama H, Kanakura Y, et al.
- Journal Title
  
  Oncogene 24・55
  
  Pages: 8144-8153
- Data Source
  KAKENHI-PROJECT-17590996
[Journal Article] Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1.2005
- Author(s)
  Ishiko E, Matsumura I, Shibayama H, Kanakura Y, et al.
- Journal Title
  
  J.Biol.Chem. 280・6
  
  Pages: 4929-4939
- Data Source
  KAKENHI-PROJECT-17590996
[Journal Article] 用語解説「Anamorsin」2005
- Author(s)
  柴山浩彦, 金倉譲
- Journal Title
  
  分子細胞治療 4・4
  
  Pages: 350-351
- Data Source
  KAKENHI-PROJECT-17590996
[Journal Article] Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis.2004
- Author(s)
  Shibayama H
- Journal Title
  
  J Exp Med. 199・4
  
  Pages: 581-592
- Data Source
  KAKENHI-PROJECT-16590938
[Journal Article] Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis.2004
- Author(s)
  Shibayama, H., et al.
- Journal Title
  
  J Exp Med 199
  
  Pages: 581-592
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15591006
[Journal Article] Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis.2004
- Author(s)
  Shibayama H, et al.
- Journal Title
  
  J.Exp.Med. 199
  
  Pages: 581-592
- Data Source
  KAKENHI-PROJECT-16659255
[Journal Article] Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis.2004
- Author(s)
  H.Shibayama, et al.
- Journal Title
  
  J.Exp.Med. 199
  
  Pages: 581-592
- Data Source
  KAKENHI-PROJECT-15591006
[Journal Article] Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis.2004
- Author(s)
  Shibayama, H., et al.
- Journal Title
  
  J.Exp.Med. 199
  
  Pages: 581-592
- Data Source
  KAKENHI-PROJECT-16590937
[Journal Article] Identification of a cytokine-induced antiapototic molecule anamorsin essential for definitive hematopoiesis.2004
- Author(s)
  Shibayama H, et al.
- Journal Title
  
  J Exp Med 199
  
  Pages: 581-592
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591006
[Journal Article] Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis.2004
- Author(s)
  Shibayama H, et al.
- Journal Title
  
  J.Exp.Med. 199
  
  Pages: 581-592
- Data Source
  KAKENHI-PROJECT-16390278
[Journal Article] Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis.2004
- Author(s)
  Shibayama H, et al.
- Journal Title
  
  J.Exp.Med. 199
  
  Pages: 581-592
- Data Source
  KAKENHI-PROJECT-16209033
[Presentation] Late vs Early Response and Depth of Response Are Associated with Improved Outcomes in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IRd) or Placebo-Lenalidomide-Dexamethasone (pbo-Rd) in the Phase 3 TOURMALINE-MM2 Trial2021
- Author(s)
  Paul G. Richardson, Thierry Facon, Sophie Rigaudeau, Eric Voog, Sung-Soo Yoon, Kenshi Suzuki, Hirohiko Shibayama, Xiaoquan Zhang, Arun Kumar, Philip Twumasi-Ankrah, Richard Labotka, Robert M. Rifkin, Sagar Lonial, Shaji K Kumar, S. Vincent Rajkumar, Philippe Moreau
- Organizer
  The American Society of Hematology 63rd Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Genetic features of AML with MLL-rearrangement and NPM1 mutation: HM-SCREEN-JAPAN012021
- Author(s)
  SunGi Chi, Kentaro Fukushima, Hirohiko Shibayama, Naoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Suguru Fukuhara, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] A Phase 2b study of an oral HDAC inhibitor HBI-8000 in patients with relapsed or refractory ATL2021
- Author(s)
  Tatsuro Jo, Atae Utsunomiya, Koji Izutsu, Hirohiko Shibayama, Kazuya Shimoda, Yasushi Takamatsu, Kuniko Takano, Kunihiro Tsukasaki, Jun Taguchi, Kentaro Yonekura, Shinichi Makita, Mireille Gillings, Hiroshi Onogi, Kensei Tobinai
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Genetic features of AML with normal karyotype: HM-SCREEN-JAPAN012021
- Author(s)
  SunGi Chi, Masamitsu Yanada, Kazuhito Yamamoto, Naoko Hosono, Takahiro Yamauchi, Kentaro Fukushima, Hirohiko Shibayama, Seiichiro Katagiri, Akihiko Gotoh, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Suguru Fukuhara, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Efficacy of elotuzumab plus lenalidomide and dexamethasone for MM: A retrospective analysis from KMF.2021
- Author(s)
  Shin-ichi Fuchida, Tomoki Ito, Kensuke Ota, Hirohiko Shibayama, Kentaro Fukushima, Hirokazu Tanaka, Yuji Shimura, Kazunori Imada, Hideo Yagi, Satoshi Yoshihara, Masayuki Hino, Naoki Hosen, Akifumi Takaori, Itaru Matsumura, Shosaku Nomura, Chihiro Shimazaki, Junya Kuroda
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Two-year follow-up data of Phase II study of Tirabrutinib, a second-generation bruton’s tyrosine kinase inhibitor, in patients with treatment-naive or relapsed/refractory Waldenstrom’s macroglobulinemia.2021
- Author(s)
  Kenshi Suzuki, Naohiro Sekiguchi, Shinya Rai, Wataru Munakata, Hiroshi Handa, Hirohiko Shibayama, Tomoyuki Endo, Yasuhito Terui, Noriko Iwaki, Noriko Fukuhara, Hiro Tatetsu, Shinsuke Iida, Takayuki Ishikawa, Daisuke Iguchi, Koji Izutsu
- Organizer
  The American Society of Hematology 63rd Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Clinical significance of FLT3 mutations in a NGS multicenter study of AML: HM-SCREEN-JAPAN012021
- Author(s)
  Kentaro Fukushima, Hirohiko Shibayama, SunGi Chi, Nohoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Suguru Fukuhara, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Very elderly patients with myeloma: a multicenter retrospective analysis from Kansai Myeloma forum.2021
- Author(s)
  Yusuke Okayama, Teruhito Takakuwa, Yuji Shimura, Nobuhiko Uoshima, Satoshi Yoshihara, Junya Kanda, Hirohiko Shibayama, Kentaro Fukushima, Kensuke Ota, Hideo Yagi, Shosaku Nomura, Chihiro Shimazaki, Itaru Matsumura, Akifumi Takaori, Naoki Hosen, Masayuki Hino, Junya Kuroda
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Very Low-Dose Dasatinib Is a Safe and Effective Therapy for Elderly Patients with Newly-Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results from the Davlec Study, a Single-Arm, Multicenter, Phase 2 Trial2021
- Author(s)
  Takashi Kumagai, Kazunori Murai, Hiroshi Ureshino, Hideo Tanaka, Takaaki Ono, Katsumichi Fujimaki, Hirohiko Shibayama, Chisaki Mizumoto, Tomoharu Takeoka, Katsuhiro Io, Takeshi Kondo, Masatomo Miura, Yosuke Minami, Takayuki Ikezoe, Jun Imagawa, Ayako Takamori, Atsushi Kawaguchi, Junichi Sakamoto, Shinya Kimura
- Organizer
  The American Society of Hematology 63rd Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Genomic analysis of TP53 mutations in a multicenter NGS study of AML: HM-SCREEN-Japan01.2021
- Author(s)
  Kentaro Fukushima, SunGi Chi, Hirohiko Shibayama, Nohoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Suguru Fukuhara, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] A case of PTCL-NOS with central nervous system involvement successfully treated with oral forodesine.2021
- Author(s)
  Yukio Doi, Takafumi Yokota, Hirohiko Shibayama, Kana Matsumoto, Masako Kurashige, Kenji Nozaki, Kouki Yoshida, Makiko Suga, Midori Koike, Jun Toda, Keigo Akuta, Akihisa Hino, Tomoaki Ueda, Yasuhiro Nagate, Jiro Fujita, Kentaro Fukushima, Naoki Hosen
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Genetic features of AML requiring hematopoietic stem cell transplantation: HM-SCREEN-JAPAN012021
- Author(s)
  Motoki Eguchi, Takanobu Morishita, SunGi Chi, Kentaro Fukushima, Hirohiko Shibayama, Naoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Suguru Fukuhara, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Genomic analysis of relapsed AML with RUNX1-RUNX1T1 in a comprehensive NGS multicenter study of AML2021
- Author(s)
  Seiichiro Katagiri, Daigo Akabane, Akihiko Gotoh, SunGi Chi, Kentaro Fukushima, Hirohiko Shibayama, Naoko Hosono, Takahiro Yamauchi, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Nobel web application predicting patient-specific prognosis in MM from KMF using machine learning.2021
- Author(s)
  Teruhito Takakuwa, Hiroshi Okamura, Shin-ichi Fuchida, Yuji Shimura, Junya Kanda, Nobuhiko Uoshima, Hirohiko Shibayama, Satoshi Yoshihara, Hideo Yagi, Masayuki Hino, Yuzuru Kanakura, Junya Kuroda, Akifumi Takaori, Chihiro Shimazaki, Itaru Matsumura, Shosaku Nomura
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Using ImmunoFISH to determine lymphoid neoplasm relapse after sex-mismatched HSCT or PTLD occurrence2021
- Author(s)
  Ryumei Kurashige, Masako Kurashige, Yosuke Okada, Kohei Higuchi, Akihisa Hino, Takako Miyamura, Michiko Ichii, Kentaro Fukushima, Makoto Takeuchi, Akihisa Sawada, Masami Inoue, Hirohiko Shibayama, Eiichi Morii, Naoki Hosen
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Clinical Significance of FLT3 Mutations in a Comprehensive NGS Multicenter Study of AML: HM-Screen-Japan 012021
- Author(s)
  Kentaro Fukushima, Hirohiko Shibayama, SungGi Chi, Naoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Makoto Yoshimitsu, Kenji Ishitsuka, Takaaki Ono, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinori Nakamura, Suguru Fukuhara, Koji Izutsu, Nobuhiko Yamauchi, Junichiro Yuda, Yosuke Minami
- Organizer
  The American Society of Hematology 63rd Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] A mutation profiling multicenter study of patients with AML: HM-SCREEN-JAPAN012021
- Author(s)
  Naoko Hosono, Takahiro Yamauchi, SunGi Chi, Kentaro Fukushima, Hirohiko Shibayama, Seiichiro Katagiri, Akihiko Gotoh, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Suguru Fukuhara, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] A Phase 2b study of an oral HDAC inhibitor HBI-8000 in patients with relapsed or refractory PTCL2021
- Author(s)
  Hidetsugu Kawai, Jun Ando, Ilseung Choi, Junya Kuroda, Mitsutoshi Kurosawa, Hong Ghi Lee, Jae Hoon Lee, Won Sik Lee, Hironobu Minami, Hirokazu Nagai, Hirohiko Shibayama, Takeo Shindo, Kenji Tsukamoto, Kunihiro Tsukasaki, Toshiki Uchida, Shinya Rai, Deok Hwan Yang, Shinichiro Yoshida, Mireille Gillings, Kensei Tobinai
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Genetic features of AML with IDH1/IDH2 mutation: HM-SCREEN-JAPAN012021
- Author(s)
  Hirotaka Nakamura, SunGi Chi, Kentaro Fukushima, Hirohiko Shibayama, Naoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Suguru Fukuhara, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study.2020
- Author(s)
  Hitoshi Hanamoto, Yasuyoshi Morita, Motoshi Ichikawa, Yasuhito Nannya, Hirohiko Shibayama, Yoshinobu Maeda, Tomoko Hata, Toshihiro Miyamoto, Hiroshi Kawabata, Kazuto Takeuchi, Hiroko Tanaka, Junji Kishimoto, Satoru Miyano, Itaru Matsumura, Seishi Ogawa, Koichi Akashi, Yuzuru Kanakura, Kinuko Mitani
- Organizer
  The American Society of Hematology 62nd Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] A multi-center retrospective analysis of relapsed/refractory FL after 3rd-line chemotherapy2020
- Author(s)
  Shigeo Fuji，Yuma Tada，Kenji Nozaki，Hideaki Saito， Takayuki Ozawa，Toru Kida，Satoru Kosugi，Hiroyuki Sugahara， Hirokazu Ikeda，Koji Hashimoto，Takahiro Karasuno，Shuji Ueda，Jun Ishikawa，Hirohiko Shibayama
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Genomic Analysis of FLT3 Mutations in a Comprehensive NGS Multicenter Study of AML: HM-Screen-Japan 01.2020
- Author(s)
  Kentaro Fukushima, SungGi Chi, , Hirohiko Shibayama, , Naoko Hosono, Kenichi Miyamoto, Yosuke Minami
- Organizer
  The American Society of Hematology 62nd Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Signal transducing adaptor protein (STAP)-2 accelerates graft-versus-host-disease2020
- Author(s)
  Hideaki Saito，Michiko Ichii，Jun Toda，Yuichi Kitai，Ryuta Muromoto，Junichi Kashiwakura，Kodai Saitoh，Takafumi Yokota，Hirohiko Shibayama，Tadashi Matsuda，Kenji Oritani，Yuzuru Kanakura，Naoki Hosen.
- Organizer
  第82回日本血液学会学術集会・総会
- Data Source
  KAKENHI-PROJECT-19K08815
[Presentation] PET-CT after bendamustine + rituximab for follicular lymphoma in first relapse can predict PFS2020
- Author(s)
  Miyuki Okura，Koji Kato，Junji Suzumiya，Koji Izutsu，Momoko Nishikori, Hirohiko Shibayama，Yoshinobu Maeda，Kenichi Yoshimura，Ukihide Tateishi，Toshihiro Miyamoto，Jun Ishikawa，Shinya Rai，Tsutomu Takahashi，Koichi Akashi，Yuzuru Kanakura
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Induction therapies for transplant-ineligible NDMM: retrospective analysis of 547 cases from KMF2020
- Author(s)
  Yuji Shimura，Hirohiko Shibayama，Aya Nakaya，Ryosuke Yamamura，Kazunori Imada，Masayuki Hino，Akifumi Takaori，Itaru Matsumura，Yuzuru Kanakura，Shosaku Nomura
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Special AT-rich sequence binding protein 1 induces antigen presenting function in splenic B cells2020
- Author(s)
  Takayuki Ozawa, Takafumi Yokota, Ritsuko Nakai, Yasuhiro Shingai, Tomoaki Ueda, Yukiko Doi, Hirohiko Shibayama, Naoki Hosen
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] The Phase 3 TOURMALINE-MM2 Trial: Oral Ixazomib, Lenalidomide, and Dexamethasone (IRd) Vs Placebo-Rd for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM).2020
- Author(s)
  Thierry Facon, Christopher P. Nizar Bahlis, Fritz Offner, Darrell J White, Lotfi Benboubker, Sophie Rigaudeau, Philippe Rodon, Sung-Soo Yoon, Kenshi Suzuki, Hirohiko Shibayama, Xiaoquan Zhang, Godwin Yung, Robert M. Rifkin, Philippe Moreau, Sagar Lonial, Shaji K. Kumar, Paul G. Richardson, Vincent Rajkumar
- Organizer
  The American Society of Hematology 62nd Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Subanalysis of FLT3 mutations in comprehensive NGS multicenter study of AML: HM-SCREEN-Japan 012020
- Author(s)
  Kentaro Fukushima, Hirohiko Shibayama, Kenichi Miyamoto, Naoko Hosono, Takahiro Yamauchi, Nobuhiko Yamauchi, Yosuke Minami
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Daratumumab/Len/Dex (D-Rd) in non-transplant NDMM: Update of MMY1006 (Japanese patients) and MAIA2020
- Author(s)
  Saad Z. Usmani，Hirohiko Shibayama，Kenshi Suzuki，Shinsuke Iida，Thierry Facon，Nizar J. Bahlis，Hiroshi Yamazaki，Jianping Wang，Rian Van Rampelbergh，Hiroyuki Takamatsu
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Multi-color analysis of immune response of myeloma patients under lenalidomide maintenance2020
- Author(s)
  Kenji Nozaki，Yuki Fujioka，Jun Ishikawa，Masato Iida，Masaru Shibata，Satoru Kosugi，Hirohiko Shibayama
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Carfilzomib and dexamethasone (Kd) with/without daratumumab (D): subgroup analysis in Asian patients2020
- Author(s)
  Kenshi Suzuki，Chang-Ki Min，Kihyun Kim，Je-Jung Lee，Hirohiko Shibayama，Po-Shen Ko，Shang-Yi Huang，Sin-Syue Li，Bifeng Ding，Monica Khurana，Seasea Gao，Shinsuke Iida
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] A phase 1 study of acalabrutinib in Japanese patients with B-cell malignancies2020
- Author(s)
  Hirokazu Nagai，Kiyoshi Ando，Daisuke Ennishi，Hirohiko Shibayama，Junji Suzumiya，Kazuhito Yamamoto，Satoshi Ichikawa，Koji Kato，Kyoya Kumagai，Priti Patel，Sakura Iizumi，Nobuya Hayashi，Hisashi Kawasumi，Koji Izutsu
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Polatuzumab vedotin with bendamustine and rituximab in r/ r DLBCL (P-DRIVE): A phase 2 study in Japan2020
- Author(s)
  Hirohiko Shibayama，Shinya Rai，Koji Izutsu，Motoko Yamaguchi， Jun Takizawa，Misato Hashizume，Yasuhito Terui
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Patient demographics in a prospective observational study of plasma cell neoplasms in Japan2020
- Author(s)
  Hirohiko Shibayama，Mitsuhiro Itagaki，Hiroshi Handa，Akihiro Yokoyama，Morio Sawamura，Toshiki Saito，Itaru Matsumura，Koichi Akashi，Shinsuke Iida
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Autonomous TGFβ signaling promotes phenotypic variations of human AML cells2020
- Author(s)
  Yasuhiro Shingai，Takafumi Yokota，Ritsuko Nakai，Takayuki Ozawa， Tomoaki Ueda，Yukiko Doi，Tomohiko Ishibashi，Michiko Ichii， Hirohiko Shibayama，Yuzuru Kanakura，Naoki Hosen
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] ASXL1 mutations predict a poor response to darbepoetin alfa in anemic patients with low-risk MDS2020
- Author(s)
  Hirohiko Shibayama, Yasuyoshi Morita, Motoshi Ichikawa, Yasuhito Nannya, Hitoshi Hanamoto, Yoshinobu Maeda, Tomoko Hata, Toshihiro Miyamoto, Hiroshi Kawabata，Kazuto Takeuchi，Hiroko Tanaka，Junji Kishimoto，Satoru Miyano，Itaru Matsumura，Seishi Ogawa, Koichi Akashi, Yuzuru Kanakura, Kinuko Mitani
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Special AT-Rich Sequence Binding Protein 1 Is Involved In the Formation of Germinal Center B Cells in the Murine Spleen.2019
- Author(s)
  Ozawa T, Yokota T, Shingai Y, Ueda T, Doi Y, Shibayama H, Kanakura Y
- Organizer
  The 10th JSH International Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] ENTEROCOCCUS-PREDOMINANT INTESTINAL MICROBIOTA INDICATES POOR PROGNOSIS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION.2019
- Author(s)
  Shinsuke Kusakabe, Kentaro Fukushima, Takafumi Yokota, Ritsuko Nakai, Akihisa Hino, Yasuhiro Nagate, Yukiko Doi, Jiro Fujita, Daisuke Motooka, Shota Nakamura, Hirohiko Shibayama, Yuzuru Kanakura
- Organizer
  The 24th European Hematology Association
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] 多発性骨髄腫におけるクリニカルシークエンスの実行可能性の研究2019
- Author(s)
  李政樹, 安田貴彦, 半田寛, 石田禎夫, 柴山浩彦, 安倍正博, 金森貴之, 真田昌, 服部浩佳, 西島大, 倉橋浩樹, 白石友一, 山本松雄, 齋藤明子, 宮野悟, 小川誠司, 堀部敬三, 飯田真介
- Organizer
  第81回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] 末梢性T細胞リンパ腫の多施設共同後方視的研究：自家移植と予後との関連性2019
- Author(s)
  多田雄真, 藤重夫, 政家寛明, 吉田均, 小杉智, 菅原浩之, 上田周二, 柴山浩彦, 石川淳, 金倉譲
- Organizer
  第81回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Special AT-rich Sequence Binding Protein 1 (SATB1) is markedly expressed in the Dark Zone Germinal Center B Cells on Murine Spleen.2019
- Author(s)
  Ozawa T, Yokota T, Shingai Y, Ueda T, Doi Y, Shibayama H, Kanakura Y
- Organizer
  The 24th European Hematology Association
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Contributions of high number of PD-1+ tumor infiltrating lymphocytes to early onset of PTLD.2019
- Author(s)
  Hideaki Saito, Hiroaki Miyoshi, Hirohiko Shibayama, Jun Toda, Shinsuke Kusakabe, Michiko Ichii, Jiro Fujita, Kentaro Fukushima, Tetsuo Maeda, Masao Mizuki, Kenji Oritani, Masao Seto, Takafumi Yokota, Yuzuru Kanakura, and Koichi Ohshima
- Organizer
  第81回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] The influence of tumor immune microenvironment and tumor immunity on the pathogenesis, treatment and prognosis of post-transplant lymphoproliferative disorders (PTLD).2019
- Author(s)
  Hideaki Saito, Hirohiko Shibayama, Hiroaki Miyoshi, Jun Toda, Shinsuke Kusakabe, Michiko Ichii, Jiro Fujita, Kentaro Fukushima, Takafumi Yokota, Tetsuo Maeda, Maso Mizuki, Kenji Oritani, Masao Seto, Koichi Ohshima, Yuzuru Kanakura
- Organizer
  15th International Conference on Malignant Lymphoma
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Fatal fungemia caused by Exophiala genus in two patients after allogeneic stem cell transplantation.2019
- Author(s)
  Nakai R, Fukushima K, Hino A, Kusakabe S, Nagate Y, Fujita J, Yokota T, Shibayama H, Kanakura Y.
- Organizer
  第41回造血細胞移植学会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] A Novel UniFrac-Based Analytical Method for Determining Sequential Changes in　Gut Microbiota After Hematopoietic Stem Cell Transplantation.2019
- Author(s)
  Shinsuke Kusakabe, Kentaro Fukushima, Takafumi Yokota, Jiro Fujita, Daisuke Motooka, Shota Nakamura, Hirohiko Shibayama, Yuzuru Kanakura
- Organizer
  The 10th JSH International Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Elevated serum soluble interleukin-2 receptor level is a useful prognostic factor for disease-specific overall survival in patients with newly diagnosed follicular lymphoma before initiation of treatment.2019
- Author(s)
  Nozaki K, Sugahara H, Ueda S, Ishikawa J, Fuji S, Masaie H, Tada Y, Suga M, Tsutsumi K, Shibata K, Kida S, Karasuno, T Sata H, Yasumi,5 Masato Iida M, Mitsui H,Kamae T, Saito, N Murakami H, Moriyama Y, Kawakami M,Kato R, Nakae Y,Kida T, Kosugi S, Nakagawa, M Uchida Y, Azenishi Y, Sakaniwa R, Kitamura T, Shibayama H
- Organizer
  The American Society of Hematology 61th Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] A young male immunocompetent patient of atypical CD56- EBER1- extraosseous plasmacytoma with plasmablastic morphology.2019
- Author(s)
  Nakai R, Ueda Y, Wada N, Hino A, Kusakabe S, Nagate Y, Doi Y, Fujita J, Fukushima K, Yokota T, Shibayama H, Morii E, Kanakura Y.
- Organizer
  第59回リンパ網内系学会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Special AT-Rich Sequence Binding Protein 1 Is Involved In the Formation of splenic B Cells.2019
- Author(s)
  Ozawa T, Yokota T, Shingai Y, Ueda T, Doi Y, Shibayama H, Kanakura Y
- Organizer
  第81回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] 実臨床におけるイキサゾミブの治療成績：関西ミエローマフォーラムのデータベースによる多施設後方視的解析2019
- Author(s)
  高桑輝人, 山村亮介, 太田健介, 金子仁臣, 今田和典, 中谷綾, 淵田真一, 柴山浩彦, 松田光弘, 島津裕, 足立陽子, 小杉智, 内山人二, 田中宏和, 花本仁, 志村勇司, 諫田淳也, 恩田佳幸, 魚嶋伸彦, 八木秀男, 吉原哲, 日野雅之, 島崎千尋, 高折晃史, 黒田純也, 松村到, 金倉譲, 野村昌作
- Organizer
  第81回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] 抗CD38 抗体isatuximab単剤による日本人の再発難治多発性骨髄腫患者を対象とした第1/2相試験2019
- Author(s)
  李政樹, 角南一貴, 松本守生, 島崎千尋, 麻奥英毅, 丸山大, 柴山浩彦, 石澤賢一, 高松博幸, 池田宇次, 金子仁臣, 内山倫宏, 木口亨, 井山諭, 村上博和, 佐々木亨, 多田圭佑, 鈴木憲史, 飯田真介
- Organizer
  第81回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton’s Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naive or Relapsed/Refractory Waldenstrom Macroglobulinemia.2019
- Author(s)
  Wataru Munakata, Naohiro Sekiguchi, Rai Shinya, Kenshi Suzuki, Hiroshi Handa, Hirohiko Shibayama, Tomoyuki Endo, Yasuhito Terui, Noriko Iwaki, Noriko Fukuhara, Hiro Tatetsu, Shinsuke Iida, Takayuki Ishikawa, Ryota Shiibashi, Koji Izutsu
- Organizer
  The American Society of Hematology 61th Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08861
[Presentation] ESAM on the Cells of Endothelial Lineage Plays an Important Role in the Development of Definitive Hematopoiesis.2018
- Author(s)
  Tomoaki Ueda, Takafumi Yokota, Yoshihiro Uno, Tomoji Mashimo, Takao Sudo, Tomohiko Ishibashi, Yukiko Doi1, Yasuhiro Shingai, Akira Tanimura, Michiko Ichii, Sachiko Ezoe, Hirohiko Shibayama, Kenji Oritani, Yuzuru Kanakura
- Organizer
  The American Society of Hematology 60th Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09871
[Presentation] Brentuximab vedotin plus chemotherapy in high-risk, advanced-stage classical Hodgkin lymphoma patients: Results of pre-specified sub-group analyses from the ECHELON-1 study.2018
- Author(s)
  Martin Hutchings, John Radford, Andrea Gallamini, Arpad Illes, Anna Sureda, Joseph M. Connors, Alice Sykorova, Hirohiko Shibayama, Jeremy S. Abramson, Neil Chua, Jonathan W. Friedberg, Jan Koren, Ann Steward LaCasce, Lysiane Molina, Neil Josephson, Eric Song, Hina Jolin, Rachael Liu, Ashish Gautam, Stephen Ansell
- Organizer
  23rd Congress of the European Hematology Association
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09871
[Presentation] Addition of melphalan to fludarabine / busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone marrow transplantation/peripheral blood stem cell transplantation.2018
- Author(s)
  Tomoaki Ueda, Tetsuo Maeda, Kentaro Fukushima, Jiro Fujita, Shinsuke Kusakabe, Takafumi Yokota, Hirohiko Shibayama, Yoshiaki Tomiyama Yuzuru Kanakura
- Organizer
  The American Society of Hematology 60th Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09871
[Presentation] A Novel Unifrac-Based Analytical Method for Determining Sequential Changes in Gut Microbiota after Hematopoietic Stem Cell Transplantation.2018
- Author(s)
  Shinsuke Kusakabe, Kentaro Fukushima, Tetsuo Maeda, Takafumi Yokota, Ritsuko Nakai, Akihisa Hino, Yasuhiro Nagate, Jiro Fujita, Motooka Daisuke, Shota Nakamura, Hirohiko Shibayama, Yuzuru Kanakura
- Organizer
  The American Society of Hematology 60th Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09871
[Presentation] Ectonucleosidase CD39 Is Highly Expressed on ATLL Cells and Suppresses the Immune Response through theAdenosine Pathway.2018
- Author(s)
  Yasuhiro Nagate, Sachiko Ezoe, Jiro Fujita, Takafumi Yokota, Michiko Ichii, Akira Tanimura, Yukiko Doi, Tomoaki Ueda, Jun Toda, Hirohiko Shibayama, Kenji Oritani, Yuzuru Kanakura
- Organizer
  The American Society of Hematology 60th Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09871
[Presentation] 抗アポトーシス分子アナモルシンによる細胞内鉄代謝制御2018
- Author(s)
  谷村　朗, 柴山浩彦
- Organizer
  第42回日本鉄バイオサイエンス学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-16K09871
[Presentation] Hematopoietic Stem Cell Surface Antigen ESAM Depicts Autonomous Fluctuation of Leukemic Stem Cells Via TGFβ Signaling Pathway.2018
- Author(s)
  Yasuhiro Shingai, Takafumi Yokota, Takayuki Ozawa, Tomoaki Ueda, Yukiko Doi, Tomohiko Ishibashi,Takao Sudo, Akira Tanimura, Michiko Ichii, Hirohiko Shibayama and Yuzuru Kanakura
- Organizer
  The 9th JSH International Symposium 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09871
[Presentation] 抗アポトーシス分子アナモルシンと血液疾患2018
- Author(s)
  柴山浩彦
- Organizer
  血液疾患フォーラム in FUKUYAMA
- Invited
- Data Source
  KAKENHI-PROJECT-16K09871
[Presentation] Signal Transducing Adaptor Protein (STAP) Family Accelerates Gut and Thymic Graft-Versus-Host-Disease in Murine Model.2018
- Author(s)
  Hideaki Saito, Michiko Ichii, Jun Toda, Yuichi Kitai, Ryuta Muromoto, Jun-ichi Kashiwakura, Kodai Saitoh, Hirohiko Shibayama, Tadashi Matsuda, Kenji Oritani, Yuzuru Kanakura
- Organizer
  The American Society of Hematology 60th Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09871
[Presentation] 抗アポトーシス分子アナモルシンによる細胞内鉄代謝制御2018
- Author(s)
  谷村　朗, 柴山浩彦
- Organizer
  第42回日本鉄バイオサイエンス学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-17K09903
[Presentation] コンディショナルノックアウトマウスを用いた抗アポトーシス分子アナモルシンの成体造血での役割の解析2017
- Author(s)
  谷村朗、柴山浩彦、倉重隆明、濱中有理、新開泰宏、西東秀晃、戸田淳、上田智朗、長手泰宏、土居由貴子、一井倫子、横田貴史、江副幸子、金倉譲
- Organizer
  第79回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-16K09871
[Presentation] コンディショナルノックアウトマウスを用いた抗アポトーシス分子アナモルシンの成体造血における役割の解析2017
- Author(s)
  谷村朗、柴山浩彦、倉重隆明、濱中有理、新開泰宏、西東秀晃、戸田淳、上田智朗、長手泰宏、土居由貴子、一井倫子、横田貴史、江副幸子、金倉譲
- Organizer
  第79回日本血液学会
- Data Source
  KAKENHI-PROJECT-17K09903
[Presentation] Anamorsin is essential for B-cell terminal differentiation.2016
- Author(s)
  Hamanaka Y, Shibayama H, Tanimura A, Yokota T, Ezoe S, Ichii M, Ishibashi T, Doi Y, Nagate Y, Oritani K, Kanakura Y
- Organizer
  21st Congress of European Hematology Association
- Place of Presentation
  The Bella Center, Copenhagen, Denmark
- Year and Date
  2016-06-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09871
[Presentation] Anamorsin plays important roles in B-cell development2016
- Author(s)
  濱中有理，柴山浩彦, 谷村朗, 横田貴史, 江副幸子, 一井倫子, 石橋知彦, 土居由貴子, 長手泰宏, 織谷健司, 金倉譲
- Organizer
  第78回日本血液学会学術集会
- Place of Presentation
  パシフィコ横浜, 神奈川
- Year and Date
  2016-10-14
- Data Source
  KAKENHI-PROJECT-16K09871
[Presentation] Second primary malignancies among patients with myeloma-related-diseases in KMF database2015
- Author(s)
  小杉智, 柴山浩彦, 木田亨, 中谷英仁, 太田健介, 金子仁臣, 黒田純也 , 上辻由里, 魚嶋伸彦, 足立陽子, 通堂満, 島崎千尋, 野村昌作, 日野雅之, 松村到, 谷脇雅史, 金倉譲, 高折晃史
- Organizer
  第77回日本血液学会学術集会
- Place of Presentation
  ホテル日航金沢，石川県金沢市
- Year and Date
  2015-10-18
- Data Source
  KAKENHI-PROJECT-25461449
[Presentation] Endothelial cell-selective adhesion molecule is a novel human hematopoietic stem cell markerassociated with a subset of human leukemias.2015
- Author(s)
  Ishibashi T,Yokota T, Tanaka H, Ichii1 M, Sudo T, Satoh Y, Doi Y, Tanimura A, Hamanaka Y, Ezoe S, Shibayama H, Oritani K, Kanakura Y.
- Organizer
  The 44th Annual Scientific Meeting of International Society of Exoerimental Hematology (ISEH)
- Place of Presentation
  Kyoto International Conference Center, Kyoto, Japan
- Year and Date
  2015-09-18
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25293220
[Presentation] An Anti-Apoptotic Molecule, Anamorsin, Is Upregulated in Anemia and Essential for Imperative Erythropoiesis.2015
- Author(s)
  Akira Tanimura, Hirohiko Shibayama, Yuri Hamanaka, Natsuko Fujita, Yasuhiro Nagate, Tomohiko Ishibashi, Michiko Ichii, Takafumi Yokota, Sachiko Ezoe, Kenji Oritani, and Yuzuru Kanakura
- Organizer
  第6回 JSH International Symposium 2015
- Place of Presentation
  軽井沢プリンスホテル, 長野, 北佐久郡
- Year and Date
  2015-05-22
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461401
[Presentation] Retrospective analysis of MM patients with dual refractory to bortezomib and IMiDs in KMF registry2015
- Author(s)
  小原尚恵, 柴山浩彦, 中谷英仁, 金子仁臣, 淵田真一, 八木秀男, 黒田純也, 小林正行, 野村昌作, 島崎千尋, 通堂満, 日野雅之, 松村到, 谷脇雅史, 金倉譲, 高折晃史
- Organizer
  第77回日本血液学会学術集会
- Place of Presentation
  ホテル日航金沢，石川県金沢市
- Year and Date
  2015-10-17
- Data Source
  KAKENHI-PROJECT-25461449
[Presentation] Second primary malignancies among patients with myeloma-related-diseases in KMF database.2015
- Author(s)
  小杉智, 柴山浩彦, 中谷英仁, 太田健介, 金子仁臣, 八木秀男, 田中宏和, 淵田真一, 中谷綾, 小林正行, 黒田純也 , 島崎千尋, 野村昌作, 日野雅之, 松村到, 谷脇雅史, 金倉譲, 高折晃史
- Organizer
  第77回日本血液学会学術集会
- Place of Presentation
  ホテル日航金沢，石川県金沢市
- Year and Date
  2015-10-18
- Data Source
  KAKENHI-PROJECT-25293220
[Presentation] SATB1 expression marks lymphoid-lineage-biased hematopoietic stem cells in mouse bone marrow.2015
- Author(s)
  Doi Y, Yokota T, Ishibashi1 T, Satoh Y, Ichii M, Tanimura A, Ezoe S, Shibayama H, Oritani K, Kanakura Y.
- Organizer
  The American Society of Hematology 57th Annual Meeting
- Place of Presentation
  Orange County Convention Center, Orland, FL, USA
- Year and Date
  2015-12-06
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25461449
[Presentation] An Anti-Apoptotic Molecule, Anamorsin, Is Upregulated in Anemia and Essential for Imperative Erythropoiesis.2015
- Author(s)
  Akira Tanimura, Hirohiko Shibayama, Yuri Hamanaka, Natsuko Fujita, Yasuhiro Nagate, Tomohiko Ishibashi, Michiko Ichii, Takafumi Yokota, Sachiko Ezoe, Kenji Oritani, and Yuzuru Kanakura
- Organizer
  第6回 JSH International Symposium 2015
- Place of Presentation
  軽井沢プリンスホテル, 長野県北佐久郡
- Year and Date
  2015-05-23
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25293220
[Presentation] SATB1 expression marks lymphoid-lineage-biased hematopoietic stem cells in mouse bone marrow.2015
- Author(s)
  Doi Y, Yokota T, Ishibashi1 T, Satoh Y, Ichii M, Tanimura A, Ezoe S, Shibayama H, Oritani K, Kanakura Y.
- Organizer
  The American Society of Hematology 57th Annual Meeting
- Place of Presentation
  Orange County Convention Center, Orland, FL, USA
- Year and Date
  2015-12-06
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25293220
[Presentation] Endothelial cell-selective adhesion molecule is a novel human hematopoietic stem cell markerassociated with a subset of human leukemias.2015
- Author(s)
  Ishibashi T, Yokota T, Tanaka H, Ichii1 M, Sudo T, Satoh Y, Doi Y, Tanimura A, Hamanaka Y, Ezoe S, Shibayama H, Oritani K, Kanakura Y.
- Organizer
  The 44th Annual Scientific Meeting of International Society of Exoerimental Hematology (ISEH)
- Place of Presentation
  Kyoto International Conference Center, Kyoto, Japan
- Year and Date
  2015-09-18
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25461449
[Presentation] Endothelial cell-selective adhesion molecule is a novel human hematopoietic stem cell markerassociated with a subset of human leukemias.2015
- Author(s)
  Ishibashi T,Yokota T, Tanaka H, Ichii1 M, Sudo T, Satoh Y, Doi Y, Tanimura A, Hamanaka Y, Ezoe S, Shibayama H, Oritani K, Kanakura Y.
- Organizer
  The 44th Annual Scientific Meeting of International Society of Experimental Hematology (ISEH)
- Place of Presentation
  Kyoto International Conference Center, Kyoto Japan
- Year and Date
  2015-09-17
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461401
[Presentation] ESAM is a novel human hematopoietic stem cell marker associated with a subset of human leukemias.2015
- Author(s)
  Ishibashi T,Yokota T, Tanaka H, Ichii1 M, Sudo T, Satoh Y, Doi Y, Tanimura A, Hamanaka Y, Ezoe S, Shibayama H, Oritani K, Kanakura Y.
- Organizer
  The American Society of Hematology 57th Annual Meeting
- Place of Presentation
  Orange County Convention Center, Orland, FL, USA
- Year and Date
  2015-12-05
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461401
[Presentation] Retrospective analysis of MM patients with dual refractory to bortezomib and IMiDs in KMF registry.2015
- Author(s)
  小原尚恵, 柴山浩彦, 中谷英仁, 金子仁臣, 淵田真一, 八木秀男, 黒田純也, 小林正行, 野村昌作, 島崎千尋, 通堂満, 日野雅之, 松村到, 谷脇雅史, 金倉譲, 高折晃史
- Organizer
  第77回日本血液学会学術集会
- Place of Presentation
  ホテル日航金沢，石川県金沢市
- Year and Date
  2015-10-17
- Data Source
  KAKENHI-PROJECT-25293220
[Presentation] An Anti-Apoptotic Molecule, Anamorsin, Is Upregulated in Anemia and Essential for Imperative Erythropoiesis.2015
- Author(s)
  Akira Tanimura, Hirohiko Shibayama, Yuri Hamanaka, Natsuko Fujita, Yasuhiro Nagate, Tomohiko Ishibashi, Michiko Ichii, Takafumi Yokota, Sachiko Ezoe, Kenji Oritani, and Yuzuru Kanakura
- Organizer
  第6回 JSH International Symposium 2015
- Place of Presentation
  軽井沢プリンスホテル, 長野県北佐久郡
- Year and Date
  2015-05-23
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25461449
[Presentation] An Anti-Apoptotic Molecule, Anamorsin, Is Upregulated in Anemia and Essential for Imperative Erytropoiesis2014
- Author(s)
  Akira Tanimura, Hirohiko Shibayama, Hamanaka Yuri, Natsuko Fujita, Nagate Yasuhiro, Tomohiko Ishibashi, Norimitsu Saitoh, Michiko Ichii, Takafumi Yokota, Sachiko Ezoe, Kenji Oritani and Yuzuru Kanakura
- Organizer
  he American Society of Hematology 56th Annual Meeting
- Place of Presentation
  San Francisco (USA)
- Year and Date
  2014-12-08
- Data Source
  KAKENHI-PROJECT-26461401
[Presentation] アナモルシントランスジェニックマウスを用いたアナモルシンの機能解析2014
- Author(s)
  濱中　有理、柴山　浩彦、谷村　朗、横田　貴史、江副　幸子、齊藤　則充、一井　倫子、松井　敬子、数藤　孝雄、石橋　知彦、土居　由貴子、長手　泰宏、竹本　雅子、織谷　健司、金倉　譲
- Organizer
  第76回日本血液学会学術集会
- Place of Presentation
  大阪国際会議場 (大阪)
- Year and Date
  2014-11-02
- Data Source
  KAKENHI-PROJECT-26461401
[Presentation] アナモルシントランスジェニックマウスを用いたアナモルシンの機能解析2014
- Author(s)
  濱中有理，柴山浩彦，谷村　朗，横田貴史，江副幸子，齊藤則充，一井倫子，松井敬子，数藤孝雄，石橋知彦，土居由貴子，長手泰宏，竹本雅子，織谷健司，金倉　譲
- Organizer
  第76回日本血液学会学術集会
- Place of Presentation
  大阪国際会議場, 大阪
- Year and Date
  2014-11-02
- Data Source
  KAKENHI-PROJECT-25461449
[Presentation] Anamorsin overexpression leads to dysregulation of lipopolysaccharide-stimulated B cell proliferation through Ras signaling2014
- Author(s)
  Hamanaka Y, Shibayama H, Tanimura A, Yokota T, Ezoe S, Saito N, Ichii M, Matsui K, Sudo T, Ishibashi T, Doi Y, Nagate Y, Takemoto M, Oritani K, Kanakura Y
- Organizer
  The American Society of Hematology 56th Annual Meeting
- Place of Presentation
  Moscone Center, San Francisco, CA, USA
- Year and Date
  2014-12-08
- Data Source
  KAKENHI-PROJECT-25293220
[Presentation] Anamorsin Overexpression Leads to Dysregulation of Lipopolysaccharide-Stimulated B Cell Proliferation through Ras Signaling2014
- Author(s)
  Yuri Hamanaka, Hirohiko Shibayama, Akira Tanimura, Takafumi Yokota, Sachiko Ezoe, Michiko Ichii, Norimitsu Saito, Keiko Matsui, Takao Sudo, Tomohiko Ishibashi, Yukiko Doi, Yasuhiro Nagate, Masako Takemoto, Kenji Oritani and Yuzuru Kanakura
- Organizer
  The American Society of Hematology 56th Annual Meeting
- Place of Presentation
  San Francisco (USA)
- Year and Date
  2014-12-08
- Data Source
  KAKENHI-PROJECT-26461401
[Presentation] An anti-apoptotic molecule, Anamorsin, is upregulated in anemia and　essential for erythropoiesis2014
- Author(s)
  Tanimura A, Hamanaka Y, Fujita N, Nagate Y, Ishibashi T, Matsui K, Saitoh N, Ichii M, Ezoe S, Yokota T, Oritani K, Shibayama H, Kanakura Y
- Organizer
  第76回日本血液学会学術集会
- Place of Presentation
  大阪国際会議場, 大阪
- Year and Date
  2014-10-31
- Data Source
  KAKENHI-PROJECT-25461449
[Presentation] An anti-apoptotic molecule, Anamorsin, is upregulated in anemia and　essential for erythropoiesis2014
- Author(s)
  Tanimura A, Hamanaka Y, Fujita N, Nagate Y, Ishibashi T, Matsui K, Saitoh N, Ichii M, Ezoe S, Yokota T, Oritani K, Shibayama H, Kanakura Y
- Organizer
  第76回日本血液学会学術集会
- Place of Presentation
  大阪国際会議場, 大阪
- Year and Date
  2014-10-31
- Data Source
  KAKENHI-PROJECT-25293220
[Presentation] An anti-apoptoic molecule, Anamorsin, is upregulated in anemia and essential for erythropoiesis2014
- Author(s)
  谷村　朗、濱中　有理、藤田　奈津子、長手　泰宏、石橋　知彦、松井　敬子、齊藤　則充、一井　倫子、江副　幸子、横田　貴史、織谷　健司、柴山　浩彦、金倉　譲
- Organizer
  第76回日本血液学会学術集会
- Place of Presentation
  大阪国際会議場 (大阪)
- Year and Date
  2014-10-31
- Data Source
  KAKENHI-PROJECT-26461401
[Presentation] An anti-apoptotic molecule, Anamorsin, is upregulated in anemia and essential for imperative erythropoiesis2014
- Author(s)
  Tanimura A, Shibayama H, Hamanaka Y, Fujita N, Nagate Y, Ishibashi T, Saitoh N, Ichii M, Yokota T, Ezoe S, Oritani K, Kanakura Y
- Organizer
  The American Society of Hematology 56th Annual Meeting
- Place of Presentation
  Moscone Center, San Francisco, CA, USA
- Year and Date
  2014-12-08
- Data Source
  KAKENHI-PROJECT-25293220
[Presentation] Anamorsin overexpression leads to dysregulation of lipopolysaccharide-stimulated B cell proliferation through Ras signaling2014
- Author(s)
  Hamanaka Y, Shibayama H, Tanimura A, Yokota T, Ezoe S, Saito N, Ichii M, Matsui K, Sudo T, Ishibashi T, Doi Y, Nagate Y, Takemoto M, Oritani K, Kanakura Y
- Organizer
  The American Society of Hematology 56th Annual Meeting
- Place of Presentation
  Moscone Center, San Francisco, CA, USA
- Year and Date
  2014-12-08
- Data Source
  KAKENHI-PROJECT-25461449
[Presentation] An anti-apoptotic molecule, Anamorsin, is upregulated in anemia and essential for imperative erythropoiesis2014
- Author(s)
  Tanimura A, Shibayama H, Hamanaka Y, Fujita N, Nagate Y, Ishibashi T, Saitoh N, Ichii M, Yokota T, Ezoe S, Oritani K, Kanakura Y
- Organizer
  The American Society of Hematology 56th Annual Meeting
- Place of Presentation
  Moscone Center, San Francisco, CA, USA
- Year and Date
  2014-12-08
- Data Source
  KAKENHI-PROJECT-25461449
[Presentation] アナモルシントランスジェニックマウスを用いたアナモルシンの機能解析2014
- Author(s)
  濱中有理，柴山浩彦，谷村　朗，横田貴史，江副幸子，齊藤則充，一井倫子，松井敬子，数藤孝雄，石橋知彦，土居由貴子，長手泰宏，竹本雅子，織谷健司，金倉　譲
- Organizer
  第76回日本血液学会学術集会
- Place of Presentation
  大阪国際会議場, 大阪
- Year and Date
  2014-11-02
- Data Source
  KAKENHI-PROJECT-25293220
[Presentation] MS4A3発現はヒト造血における早期骨髄球系分化の指標となる2013
- Author(s)
  石橋知彦, 横田貴史, 佐藤友亮, 数藤孝雄, 一井倫子, 柴山浩彦, 江副幸子, 谷村　朗, 藤田奈津子, 松井敬子, 濱中有理, 土居由貴子, 織谷健司, 金倉　譲
- Organizer
  第75回日本血液学会学術集会
- Place of Presentation
  ロイトン札幌・さっぽろ芸文館・札幌市教育文化会館, 北海道
- Data Source
  KAKENHI-PROJECT-25293220
[Presentation] A Rare Genetic Polymorphism In C5 Confers Poor Response To The Anti-C5 Monoclonal Antibody Eculizumab In 11 Japanese Patients With PNH2013
- Author(s)
  Nishimura J, Yamamoto M, Hayashi S, Ohyashiki K, Ando K, Noji H, Kitamura K, Eto T, Takahashi T, Masuko M, Matsumoto T, Wano Y, Shichishima T, Shibayama　H, Hase　M, Lan L, Johnson K, Tamburini P, Inazawa J, Kinoshita T, Kanakura Y
- Organizer
  The American Society of Hematology 55th Annual Meeting
- Place of Presentation
  Ernest N. Morial Convention Center, New Orleans, LA, USA
- Data Source
  KAKENHI-PROJECT-25293220
[Presentation] Endothelial Cell-Selective Adhesion Molecule Marks Human Hematopoietic Stem Cells Regardless Of The HSC Sources The American Society of Hematology2013
- Author(s)
  Ishibashi T, Saitoh N, Ezoe S, Shibayama H, Kincade PW, Oritani1 K, Kanakura Y et al
- Organizer
  55th Annual Meeting
- Place of Presentation
  New Orleans, LA, USA
- Year and Date
  2013-12-08
- Data Source
  KAKENHI-PROJECT-23591387
[Presentation] Endothelial Cell-Selective Adhesion Molecule Marks Human Hematopoietic Stem Cells Regardless Of The HSC Sources2013
- Author(s)
  Ishibashi T, Yokota T, Ichii M, Satoh Y, Sudo T, Doi Y, Fujita N, Nagate Y, Hamanaka Y, Matsui K, Tanimura A, Saitoh N, Ezoe S, Shibayama H, Kincade PW, Oritani1 K, Kanakura Y
- Organizer
  The American Society of Hematology 55th Annual Meeting
- Place of Presentation
  Ernest N. Morial Convention Center, New Orleans, LA, USA
- Data Source
  KAKENHI-PROJECT-25293220
[Presentation] MS4A3発現はヒト造血における早期骨髄球系分化の指標となる2013
- Author(s)
  石橋知彦,横田貴史,柴山浩彦,織谷健司,金倉譲ほか
- Organizer
  第75回日本血液学会学術集会
- Place of Presentation
  北海道
- Year and Date
  2013-10-12
- Invited
- Data Source
  KAKENHI-PROJECT-23591387
[Presentation] Evaluation of efficacy and safety of Bendamustine (B) treatment in Osaka Lymphoma Study Group (OLSG)2012
- Author(s)
  Kohara T, Shibayama H, Uoshima N, Terada Y, Yoshida H, Masaie H, Ishikawa J, Mugitani A, Kumura T, Okamoto S, Kamitsuji Y, Sugahara H, Nakagawa M, Kawakami M, Ishiko J, Take H, Kosugi S, Nakata S, Nagate Y, Kida T, Tominaga N, Morita T, Inoue S, Yamada M
- Organizer
  第74回日本血液学会学術集会
- Place of Presentation
  京都
- Year and Date
  2012-10-19
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] An anti-apoptotic molecule, Anamorsin, functions in both Fe/S cluster assembly and iron homeostasis2012
- Author(s)
  Tanimura A, Hamanaka Y, Tanaka H, Matsumura I, Oritani K, Shibayama H, Kanakura Y et al
- Organizer
  第74回日本血液学会学術集会
- Place of Presentation
  京都
- Year and Date
  2012-10-20
- Data Source
  KAKENHI-PROJECT-23591387
[Presentation] An anti-apoptotic molecule, Anamorsin, is essential for erythropoiesis through the regulation of cellular labile iron pool.2012
- Author(s)
  Tanimura A, Hamanaka Y, Fujita N, Doi Y, Ishibashi T, Sudo T, Matsui K, Ichii M, Saitoh N, Satoh Y, Ezoe S, Yokota T, Oritani K, Shibayama H, Kanakura Y
- Organizer
  The American Society of Hematology 54th Annual Meeting
- Place of Presentation
  Atlanta, USA
- Year and Date
  2012-12-10
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] An anti-apoptotic molecule, Anamorsin, functions in both Fe/S cluster assembly and iron homeostasis.2012
- Author(s)
  Tanimura A, Hamanaka Y, Tanaka H, Matsumura I, Ishibashi T, Sudo T, Satoh Y, Yokota T, Ezoe S, Oritani K, Shibayama H, Kanakura Y
- Organizer
  第74回日本血液学会学術集会
- Place of Presentation
  京都
- Year and Date
  2012-10-20
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] Significance of novel HSC marker ESAM expression in cord blood2012
- Author(s)
  Ishibashi T, Yokota T, Shibayama H, Oritani K, Kanakura Y et al
- Organizer
  第74回日本血液学会学術集会
- Place of Presentation
  京都
- Year and Date
  2012-10-19
- Data Source
  KAKENHI-PROJECT-23591387
[Presentation] A rare genetic polymorphism in C5 confers poor response to the anti-C5 monoclonal antibody eculizumab by nine Japanese patients with PNH2012
- Author(s)
  Nishimura J, Yamamoto M, Hayashi S, Ohyashiki K, Ando K, Noji H, Kitamura K, Eto T, Ando T, Masuko M, Shibayama H, Hase M, Lan L, Tamburini P, Inazawa J, Kinoshita T, Kanakura Y
- Organizer
  The American Society of Hematology 54th Annual Meeting
- Place of Presentation
  Atlanta, USA
- Year and Date
  2012-12-10
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] Significance of novel HSC marker ESAM expression in cord blood2012
- Author(s)
  Ishibashi T, Yokota T, Satoh Y, Sudo T, Ichii M, Shibayama H, Ezoe S, Tanimura A, Fujita N, Matsui K, Hamanaka Y, Oritani K, Kanakura Y
- Organizer
  第74回日本血液学会学術集会
- Place of Presentation
  京都
- Year and Date
  2012-10-19
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] Detection of change in LIC by MRI in a transfusion dependent MDS patient treated with deferasirox2012
- Author(s)
  Hamanaka Y, Shibayama H, Tanimura A, Oritani K, Kanakura Y
- Organizer
  第74回日本血液学会学術集会
- Place of Presentation
  京都
- Year and Date
  2012-10-20
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] Results From the ENESTnd Extension Study: Efficacy and Safety of Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)2012
- Author(s)
  Hochhaus A, Ossenkoppele G, Reiffers J, Yao M, Shibayama H, Gattermann N, Hughes TP, Saglio G, Larson RA, Hoenekopp A, Gallagher NJ, Yu R, Blakesley RE, Lobo C, Kantarjian HM
- Organizer
  Treated with Nilotinib 400 Mg Twice Daily (BID) After Suboptimal Response (SoR) or Treatment Failure (TF) to Imatinib 400 Mg Once Daily (QD) or Nilotinib 300 Mg BID. The American Society of Hematology 53rd Annual meeting
- Place of Presentation
  San Diego, USA
- Year and Date
  2012-12-10
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] Role of endothelial antigen ESAM in hematopoietic stem cells status2012
- Author(s)
  Sudo T, Yokota T, Oritani K, Satoh Y, Sugiyama T, Ishida T, Shibayama H, Ezoe S, Ichii M, Tanimura A, Fujita N, Ishibashi T, Matsui K, Hamanaka Y, Nagasawa T, Kanakura Y
- Organizer
  第74回日本血液学会学術集会
- Place of Presentation
  京都
- Year and Date
  2012-10-20
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] An anti-apoptotic molecule, Anamorsin, is essential for erythropoiesis through the regulation of cellular labile iron pool The American Society of Hematology2012
- Author(s)
  Tanimura A, Hamanaka Y, Saitoh N, Oritani K, Shibayama H, Kanakura Y et al
- Organizer
  54th Annual Meeting
- Place of Presentation
  Atlanta, USA
- Year and Date
  2012-12-10
- Data Source
  KAKENHI-PROJECT-23591387
[Presentation] An anti-apoptotic molecule, Anamorsin, functions in both Fe/S cluster assembly and iron homeostasis2012
- Author(s)
  Tanimura A, Hamanaka Y, Tanaka H, Matsumura I, Ishibashi T, Sudo T, Satoh Y, Yokota T, Ezoe S, Oritani K, Shibayama H, Kanakura Y
- Organizer
  第74回日本血液学会学術集会
- Place of Presentation
  京都
- Year and Date
  2012-10-20
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] An anti-apoptotic molecule, Anamorsin, is essential for erythropoiesis through the regulation of cellular labile iron pool2012
- Author(s)
  Tanimura A, Hamanaka Y, Fujita N, Doi Y, Ishibashi T, Sudo T, Matsui K, Ichii M, Saitoh N, Satoh Y, Ezoe S, Yokota T, Oritani K, Shibayama H, Kanakura Y
- Organizer
  The American Society of Hematology 54th Annual Meeting
- Place of Presentation
  Atlanta, USA
- Year and Date
  2012-12-10
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] Role of endothelial antigen ESAM in hematopoietic stem cells status2012
- Author(s)
  Sudo T, Yokota T, Oritani K, Shibayama H, Kanakura Y et al
- Organizer
  第74回日本血液学会学術集会
- Place of Presentation
  京都
- Year and Date
  2012-10-20
- Data Source
  KAKENHI-PROJECT-23591387
[Presentation] An anti-apoptotic molecule, Anamorsin, functions in both iron-sulfur protein assembly and cellular iron homeostasis2011
- Author(s)
  Tanimura A, Kondo Y, Tanaka H, Matsumura I, Ishibashi T, Sudo T, Satoh Y, Yokota T, Ezoe S, Oritani K, Shibayama H, Kanakura Y.
- Organizer
  The American Society of Hematology 53rd Annual meeting
- Place of Presentation
  San Diego, USA
- Year and Date
  2011-12-10
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] Nilotinib versus imatinib for newly-diagnosed CML-CP : ENESTnd 24-month update in Japanese patients2011
- Author(s)
  Nakaseko C, Nakamae H, Shibayama H, et al
- Organizer
  第73回日本血液学会学術集会
- Place of Presentation
  名古屋国際会議場(愛知県)
- Year and Date
  2011-10-14
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] OLSG 参加施設 . Clinical prognostic analysis of 465 follicular lymphoma (FL) cases from OLSG (Osaka Lymphoma Study Group) registry: OLSG cohort analysis2011
- Author(s)
  小原尚恵,柴山浩彦,武弘典,魚嶋伸彦,服部英喜,畦西恭彦,菅原浩之,橋本光司,日野雅之,冨永信彦,青笹克之,金倉譲
- Organizer
  第73回日本血液学会
- Place of Presentation
  愛知
- Year and Date
  2011-10-14
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] 当科における悪性リンパ腫に対する DeVIC 療法施行例の後方視的検討2011
- Author(s)
  大塚正恭, 前田哲生, 水木満佐央, 石橋知彦, 近藤有理, 佐多弘, 南亮太,福島健太郎, 江副幸子, 田所誠司, 柴山浩彦, 織谷健司, 金倉譲
- Organizer
  第9回日本臨床腫瘍学会学術集会
- Place of Presentation
  神奈川
- Year and Date
  2011-07-22
- Data Source
  KAKENHI-PROJECT-22591036
[Presentation] An anti-apoptotic molecule, Anamorsin, functions in both iron-sulfur protein assembly and cellular iron homeostasis2011
- Author(s)
  Tanimura A, Kondo Y, Tanaka H, Matsumura I, Ishibashi T, Sudo T, Satoh Y, Yokota T, Ezoe S, Oritani K, Shibayama H, Kanakura Y
- Organizer
  The American Society of Hematology 53rd Annual meeting
- Place of Presentation
  San Diego, USA
- Year and Date
  2011-12-10
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] Results From the ENESTnd Extension Study : Efficacy and Safety of Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP), Treated with Nilotinib 400 Mg Twice Daily (BID) After Suboptimal Response (SoR) or Treatment Failure (TF) to Imatinib 400 Mg Once Daily (QD) or Nilotinib 300 Mg BID2011
- Author(s)
  Hochhaus A, Ossenkoppele G, Reiffers J, Yao M, Shibayama H, Gattermann N, et al
- Organizer
  The American Society of Hematology 53rd Annual meeting
- Place of Presentation
  SanDiego Convention Center (USA)
- Year and Date
  2011-12-10
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] Clinical prognostic analysis of 465 follicular lymphoma (FL) cases from OLSG (Osaka Lymphoma Study Group) registry : OLSG cohort analysis2011
- Author(s)
  小原尚恵, 柴山浩彦, ら
- Organizer
  第73回日本血液学会学術集会
- Place of Presentation
  名古屋国際会議場(愛知県)
- Year and Date
  2011-10-14
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] Clinical prognostic analysis of 465 follicular lymphoma (FL) cases from OLSG (Osaka Lymphoma study Group) registry : OLSG cohort analysis2011
- Author(s)
  小原尚恵, 柴山浩彦, 金倉譲, ほか
- Organizer
  第73回日本血液学会学術集会
- Place of Presentation
  名古屋国際会議場(愛知)
- Year and Date
  2011-10-14
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] An anti-apoptotic molecule, Anamorsin, functions in both iron-sul fur protein assembly and cellular iron homeostasis2011
- Author(s)
  Tanimura A, Kondo Y, Oritani K, Shibayama H, Kanakura Y, et al
- Organizer
  The American Society of Hematology 53rd Annual meeting
- Place of Presentation
  SanDiego Convention Center (USA)
- Year and Date
  2011-12-10
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] The incidence of BCR-ABL mutations in patients (pts) with newly diagnosed chronic myeloid leukemia (CML) in chronic phase (CP) treated with nilotinib or imatinib in ENESTnd : 24-month follow-up2011
- Author(s)
  Saglio G, Kantarjian H, Reiffers J, Jootar S, Kalaycio ME, Shibayama H, et al
- Organizer
  American Society of Clinical Oncology 47th Annual Meeting
- Place of Presentation
  Mccormick place, Chicago (USA)
- Year and Date
  2011-06-03
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] Nilotinib versus imatinib for newly-diagnosed CML-CP: ENESTnd 24-month update in Japanese patients.2011
- Author(s)
  Nakaseko C, Nakamae H, Shibayama H, Kurokawa M, Fukuda T, Kanda Y, Nagai T, Ohnishi K, Matsumura I, Matsuda A, Amagasaki T, Kojo N, Ito K.
- Organizer
  第73回日本血液学会学術集会
- Place of Presentation
  愛知
- Year and Date
  2011-10-14
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] An anti-apoptotic molecule, Anamorsin, functions in both iron-sulfur protein assembly and cellular iron homeostasis2011
- Author(s)
  Tanimura A, Kondo Y, Shibayama H, Kanakura Y, et al
- Organizer
  The American Society of Hematology 53rd Annual meeting
- Place of Presentation
  San Diego Convention Center (USA)
- Year and Date
  2011-12-10
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] A cell-death defying factor, anamorsin, yields cell growth through inactivation of p38MAPK2010
- Author(s)
  齋藤有理, 柴山浩彦, 金倉譲, 他
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  大阪国際会議場、大阪
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] cell-death-defying factor, anamorsin contributes cell growth throughinactivation of p38MAPK.2010
- Author(s)
  Saito Y, Shibayama H, Tanaka H, Tanimura A, Matsumura I, Kanakura Y.
- Organizer
  15th Congress of the European Hematology Association
- Place of Presentation
  Barcelona, Spain
- Year and Date
  2010-06-10
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] Central nervous system events in patients with diffuse large B-cell lymphoma in the rituximab era2010
- Author(s)
  Tomita N, Shibayama H, et al.
- Organizer
  The American Society of Hematology 52nd Annual meeting
- Place of Presentation
  OCCC, Orlando (USA)
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] A Cell-Death-Defying Factor, Anamorsin, Contributes Cell Growth through Binding with PICOT and Inactivation of PKCs and p38MAPK.2010
- Author(s)
  Shibayama H, Saito Y, et al.
- Organizer
  The American Society of Hematology 52nd Annual meeting
- Place of Presentation
  Orange County Convention Center, Orlando (USA)
- Year and Date
  2010-12-04
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] 抗細胞死分子アナモルシンは、p38MAPKを不活化し細胞増殖をもたらす2010
- Author(s)
  齋藤有里、柴山浩彦, ら
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  大阪国際会議場(大阪)
- Year and Date
  2010-09-22
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] Efficacy and safety of nilotinib in chronic phase (CP) chronic myeloid leukemia (CML) patients (Pts) with type 2 diabetes in the ENESTnd trial2010
- Author(s)
  Saglio G, Shibayama H, et al.
- Organizer
  The American Society of Hematology 52nd Annual meeting
- Place of Presentation
  OCCC, Orlando (USA)
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] A cell-death-defying factor, anamorsin, contributes cell growth through binding with PICOT and inactivation of PKCs and p38MAPK2010
- Author(s)
  Shibayama H, Kanakura Y, et al.
- Organizer
  The American Society of Hematology 52nd Annual meeting
- Place of Presentation
  OCCC, Orlando(USA)
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] A CELL-DEATH-DEFYING FACTOR, ANAMORSIN, CONTRIBUTES CELL GROWTH THROUGH INACTIVATION OF P38 MAPK2010
- Author(s)
  Saito Y, Shibayama H, et al.
- Organizer
  The 15th Congress of European Hematology Association
- Place of Presentation
  The Gran Via Conference Center, Barcelona (Spain)
- Year and Date
  2010-06-11
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] A cell-death-defying factor, anamorsin, contributes cell growth through binding with PICOT and inactivation of PKCs and p38MAPK2010
- Author(s)
  Shibayama H, Saito Y, Tanimura A, Tanaka H, Matsumura I, Kanakura Y
- Organizer
  The American Society of Hematology 52nd Annual meeting
- Place of Presentation
  Orlando, USA
- Year and Date
  2010-12-04
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] Essential role of an anti-apoptotic molecule Anamorsin for both intrinsic and extrinsic regulation of murine fetal liver hematopoiesis2010
- Author(s)
  Tanimura A, Tanaka H, Saito Y, Shibayama H, Matsumura I, Kanakura Y
- Organizer
  The 15th Congress of the European Hematology Association
- Place of Presentation
  Barcelona, Spain
- Year and Date
  2010-06-10
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] Efficacy and safety of nilotinib versus imatinib in Japanese patients with newly diagnosed CML-CP2010
- Author(s)
  Shibayama H, et al.
- Organizer
  第72回日本血液学会学術集会
- Place of Presentation
  パシフィコ横浜、神奈川
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] Efficacy and safety of nilotinib versus imatinib in Japanese patients with newly diagnosed CML-CP2010
- Author(s)
  Shibayama H, Nakamae H, Kurokawa M, Fukuda T, Nakaseko C, Kanda Y, Ohnishi K, Matsuda A, Nagai T, Maeda Y, Amagasaki T, Kawahara E, Yanada M
- Organizer
  第72回日本血液学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] Essential role of an anti-apoptotic molecule Anamorsin for both intrinsic and extrinsic regulation of murine fetal liver hematopoiesis2010
- Author(s)
  Tanimura A, Shibayama H, Kanakura Y, et al.
- Organizer
  15th Congress of the European Hematology Association
- Place of Presentation
  BICC, Barcelona (Spain)
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] Essential role of an anti-apoptotic molecule Anamorsin for both intrinsic and extrinsic regulation of murine fetal liver hematopoiesis2010
- Author(s)
  Tanimura A, Tanaka H, Saito Y, Shibayama H, Matsumura I, Kanakura Y
- Organizer
  15th Congress of the European Hematology Association
- Place of Presentation
  Barcelona, Spain
- Year and Date
  2010-06-10
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] Change of BCR-ABL levels during nilotinib and imatinib treatment for newly diagnosed CML-CP2010
- Author(s)
  Imai Y, Shibayama H, et al.
- Organizer
  第72回日本血液学会学術集会
- Place of Presentation
  パシフィコ横浜、神奈川
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] A cell-death-defying factor, anamorsin, contributes cell growth through binding with PICOT and inactivation of PKCs and p38MAPK2010
- Author(s)
  Shibayama H, Saito Y, Tanimura A, Tanaka H, Matsumura I, Kanakura Y
- Organizer
  The American Society of Hematology 52nd Annual meeting
- Place of Presentation
  Orlando, USA
- Year and Date
  2010-12-04
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] Anti-apoptotic molecule Anamorsin is crucial for stromal function to support embryonic hematopoiesis2010
- Author(s)
  Tanimura A, Tanaka H, Saito Y, Shibayama H, Matsumura I, Kanakura Y
- Organizer
  第72回日本血液学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] Clinical significance of WT1 mRNA expression level in patients with myelodysplastic syndrome(MDS)2010
- Author(s)
  Nannya Y, Shibayama H, et al.
- Organizer
  第72回日本血液学会学術集会
- Place of Presentation
  パシフィコ横浜、神奈川
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] Anti-apoptotic molecule Anamorsin is crucial for stromal function to support embryonic hematopoiesis2010
- Author(s)
  Tanimura A, Shibayama H, Kanakura Y, et al.
- Organizer
  第72回日本血液学会学術集会
- Place of Presentation
  パシフィコ横浜、神奈川
- Data Source
  KAKENHI-PROJECT-22390194
[Presentation] A cell-death-defying factor, anamorsin, yields cell growth through inactivation of p38MAPK(抗細胞死分子アナモルシンは、p38MAPK を不活化し細胞増殖をもたらす)2010
- Author(s)
  齋藤有里, 柴山浩彦, 田中宏和, 谷村朗 , 松村到 , 金倉譲
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  大阪
- Year and Date
  2010-09-22
- Data Source
  KAKENHI-PROJECT-22591034
[Presentation] (ポスター)びまん性大細胞型B細胞リンパ腫(DLBCL)におけるアナモルシンの発現 : アナモルシンは低リスク症例において生物学的予後因子となりうる2008
- Author(s)
  小原尚恵, 柴山浩彦, 村田信介, 齋藤有理, 杉本夕奈, 松村到, 青笹克之, 金倉譲
- Organizer
  第105回日本内科学会総会・講演会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-19591108
[Presentation] (シンポジウム)抗死分子アナモルシンとリンパ系腫瘍2007
- Author(s)
  柴山浩彦
- Organizer
  第69回日本血液学会・第49回日本臨床血液学会合同総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-19591108
[Presentation] (ポスター)Anamorsin is a prognostic biomarker for low IPI DLBCL patients2007
- Author(s)
  齋藤有理, 柴山浩彦, 沈沢尚恵, 村田信介, 松村到, 青笹克之, 金倉譲
- Organizer
  第66回日本癌学会総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-19591108
[Presentation] (ポスター)FIP1L1/PDGFRα imposes commitment towards eosinophilic lineage on hematopoietic stem/progenitor cells2007
- Author(s)
  福島健太郎, 松村到, 江副幸子, 田中宏和, 柴山浩彦, 水木満佐央, 金倉譲
- Organizer
  第66回日本癌学会総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-19591108
[Presentation] Kanakura Y(Poster)FIP1L1/PDGFR[alpha] imposes commitment towards eosinophil lineage on hematopoietic stem/ progenitor cells by modifying the expression and function of lineage specific transcription factors2007
- Author(s)
  Fukushima K, Matsumura I, Ezoe S, Shibayama H, Yokota T, Tanaka H
- Organizer
  American Society of Hematology 49th Annual meeting
- Place of Presentation
  tlanta, USA
- Data Source
  KAKENHI-PROJECT-19591108
[Presentation] ポスター)ELISA法による血清中アナモルシン測定系の樹立2007
- Author(s)
  杉本夕奈, 柴山浩彦, 野島順三, 齋藤有里, 村田信介, 小原尚恵, 金倉譲
- Organizer
  (第54回日本臨床検査医学会・第47回日本臨床化学会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-19591108
[Presentation] MM治療におけるMRD評価
- Author(s)
  柴山浩彦，佐多　弘，金倉　譲
- Organizer
  第51回日本癌治療学会学術集会
- Place of Presentation
  国立京都国際会館（京都）
- Invited
- Data Source
  KAKENHI-PROJECT-25461449
[Presentation] MS4A3発現はヒト造血における早期骨髄球系分化の指標となる
- Author(s)
  石橋知彦, 横田貴史, 佐藤友亮, 数藤孝雄, 一井倫子, 柴山浩彦, 江副幸子, 谷村　朗, 藤田奈津子, 松井敬子, 濱中有理, 土居由貴子, 織谷健司, 金倉　譲
- Organizer
  第75回日本血液学会学術集会
- Place of Presentation
  ロイトン札幌（札幌、北海道）
- Data Source
  KAKENHI-PROJECT-23591387
[Presentation] CD7 Expression On Blasts Of Myelodysplastic Syndromes Is Associated With Apoptosis Resistance With Decreased Expression Of The Proapoptotic Protein Bad and An Independent Unfavorable Prognostic Factor Together With The Revised IPSS Score In Patients
- Author(s)
  Hamada Y, Tamura H, Ishibashi M, Okuyama N, Kondo A, Moriya K, Ogata K, Kakumoto K, Miyazaki Y, Matsuda A, Tohyama K, Ueda Y, Kurokawa M, Shibayama H, Emi N, Mitani K, Naoe T, Sugiyama H, Inokuchi K
- Organizer
  The American Society of Hematology 55th Annual Meeting
- Place of Presentation
  Ernest N. Morial Convention Center, New Orleans, L.A., USA
- Data Source
  KAKENHI-PROJECT-25461449
[Presentation] Retrospective Analysis Of The Recent Treatment Strategies For The Patients With Myeloma-Related Diseases Registered In Kansai Myeloma Forum
- Author(s)
  Tanaka H, Kosugi S, Ohta K, Shibayama H, Kohara T, Fuchida S, Kobayashi M, Kuroda J, Nakatani E, Nomura S, Taniwaki M, Takaori A, Shimazaki C, Tsudo M, Hino M, Matsumura I, Kanakura Y
- Organizer
  The American Society of Hematology 55th Annual Meeting
- Place of Presentation
  Ernest N. Morial Convention Center, New Orleans, L.A., USA
- Data Source
  KAKENHI-PROJECT-25461449
[Presentation] Endothelial Cell-Selective Adhesion Molecule Marks Human Hematopoietic Stem Cells Regardless Of The HSC Sources
- Author(s)
  Ishibashi T, Yokota T, Ichii M, Satoh Y, Sudo T, Doi Y, Fujita N, Nagate Y, Hamanaka Y, Matsui K, Tanimura A, Saitoh N, Ezoe S, Shibayama H, Kincade PW, Oritani1 K, Kanakura Y
- Organizer
  The American Society of Hematology 55th Annual Meeting
- Place of Presentation
  Ernest N. Morial Convention Center, New Orleans, LA, USA
- Data Source
  KAKENHI-PROJECT-23591387
[Presentation] WT-1 Expression Level In BM Is The Great Prognostic Marker In Three Of Classification IPSS, WPSS, and Latest Revised IPSS(IPSS-R)
- Author(s)
  Kobayashi S, Ueda Y, Kurokawa M, Ogata K, Shibayama H, Emi N, Usuki K, Ohyashiki K, Ozawa K, Miyazaki Y, Matsuda A, Tohyama K, Mitani K, Naoe T, Sugiyama H
- Organizer
  The American Society of Hematology 55th Annual Meeting
- Place of Presentation
  Ernest N. Morial Convention Center, New Orleans, L.A., USA
- Data Source
  KAKENHI-PROJECT-25461449
[Presentation] Retrospective analysis of 434 symptomatic myeloma cases registered in Kansai Myeloma Forum
- Author(s)
  柴山浩彦, 太田健介, 田中宏和, 小原尚恵, 小杉　智, 小林正行, 黒田純也, 金子仁臣, 魚嶋伸彦, 中谷英仁, 通堂　満, 島崎千尋, 高折晃史, 谷脇雅史, 野村昌作, 日野雅之, 松村　到, 金倉　譲
- Organizer
  第75回日本血液学会学術集会
- Place of Presentation
  ロイトン札幌(札幌, 北海道）
- Data Source
  KAKENHI-PROJECT-25461449

1. KANAKURA Yuzuru (20177489)

# of Collaborated Projects: 37 results

# of Collaborated Products: 104 results
2. MIZUKI Masao (80283761)

# of Collaborated Projects: 30 results

# of Collaborated Products: 7 results
3. MATSUMURA ITARU (00294083)

# of Collaborated Projects: 23 results

# of Collaborated Products: 15 results
4. ORITANI Kenji (70324762)

# of Collaborated Projects: 15 results

# of Collaborated Products: 43 results
5. SUGAHARA Hiroyuki (40362701)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
6. EZOE Sachiko (90379173)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
7. ASHIDA Takashi (30211006)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
8. TATSUMI Yoichi (60236552)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
9. SHIMADA Takahiro (90319674)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
10. TANAKA Hirokazu (40360846)

# of Collaborated Projects: 2 results

# of Collaborated Products: 14 results
11. MACHII Takashi (50124780)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
12. Ichii Michiko (30633010)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
13. Saitoh Hideaki (50815496)

# of Collaborated Projects: 2 results

# of Collaborated Products: 3 results
14. 戸田淳 (90770834)

# of Collaborated Projects: 2 results

# of Collaborated Products: 3 results
15. 横田貴史 (60403200)

# of Collaborated Projects: 2 results

# of Collaborated Products: 23 results
16. SAITOH Norimitsu (30597399)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
17. FUJITA Jiro (90608720)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
18. HAMANAKA Yuri (50722287)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
19. NISHIMURA Jun-ichi (80464246)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. KURATSUNE Hirohiko (50195533)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
21. Kurashige Ryumei (00791633)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
22. Ueda Tomoaki (60747517)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
23. 前田裕弘 (10173717)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
24. 池田弘和 (10311755)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
25. 野崎健司 (00836413)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
26. HARADA Yuka

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
27. KASHIWAGI Hirokazu

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
28. KATO Koji

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
29. 森田泰慶

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
30. 中谷英仁

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
31. 原田浩徳

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
32. 土居由貴子

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
33. 新開泰宏

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
34. 小澤孝幸

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
35. 冨山佳昭

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
36. 小川啓恭

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
37. 岡田昌也

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
38. 草壁信輔

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
39. 石橋知彦

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
40. 池田和彦

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
41. 安部正博

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Shibayama Hirohiko 柴山 浩彦

SHIBAYAMA Hirohiko 柴山 浩彦

Research Projects

Research Products

Co-Researchers

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Evaluation of iron-sulfur proteins in hematopoietic cells through anamorsinPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Clarification of the roles of anamorsin in the lymphocytes differentiation and proliferationPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of the roles of anti-apoptotic molecule, Anamorsin in immune cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of the roles of anamorsin, anti-apoptotic molecule, onsurvival and proliferation of B lymphocytesPrincipal Investigator

Principal Investigator

Shibayama Hirohiko 柴山浩彦

SHIBAYAMA Hirohiko 柴山浩彦